<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">XFRYtgTp5gMjBBcQ7VQzBVj</article-id>
      <article-id pub-id-type="other">00002</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2010001400002</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(10)09500402</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2010005000127</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Perfil cl&#237;nico-angiogr&#225;fico na doen&#231;a arterial coronariana: desfecho hospitalar com &#234;nfase nos muito idosos</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Galon</surname>
            <given-names>Micheli Zanotti</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Meireles</surname>
            <given-names>George C&#233;sar Ximenes</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kreimer</surname>
            <given-names>S&#233;rgio</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marchiori</surname>
            <given-names>Gilberto Guilherme Ajjar</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Favarato</surname>
            <given-names>Desid&#233;rio</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Almeida</surname>
            <given-names>Jo&#227;o Aparecido Pimenta de</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Capeline</surname>
            <given-names>Lorena Squassante</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Hospital do Servidor P&#250;blico Estadual Francisco Morato de Oliveira</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
        <institution content-type="orgdiv1">HC </institution>
        <institution content-type="orgdiv2">Instituto do Cora&#231;&#227;o</institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>10</month>
        <year>2010</year>
      </pub-date>
      <volume>95</volume>
      <issue>4</issue>
      <fpage>422</fpage>
      <lpage>429</lpage>
      <history>
        <date date-type="accepted">
          <day>09</day>
          <month>04</month>
          <year>2010</year>
        </date>
        <date date-type="rev-recd">
          <day>25</day>
          <month>03</month>
          <year>2010</year>
        </date>
        <date date-type="received">
          <day>10</day>
          <month>11</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: Conhecer fatores de risco e manifesta&#231;&#245;es cl&#237;nicas da doen&#231;a arterial coronariana (DAC) permite-nos intervir de maneira mais eficaz junto a uma determinada popula&#231;&#227;o. OBJETIVO: Identificar perfis cl&#237;nicos e angiogr&#225;ficos dos pacientes submetidos a cateterismo card&#237;aco, atendidos em um hospital terci&#225;rio e tratados por meio de interven&#231;&#245;es coronarianas percut&#226;neas (ICP). M&#201;TODOS: Casu&#237;stica de 1.282 pacientes submetidos a 1.410 cateterismos card&#237;acos, selecionados de mar/2007-mai/2008 em um banco de dados de um hospital geral para diagn&#243;stico de doen&#231;a arterial coronariana (DAC). Fatores de risco, indica&#231;&#227;o do exame, detalhes t&#233;cnicos da ICP e desfechos intra-hospitalares foram prospectivamente coletados. RESULTADOS: Foram 688 (54,0%) pacientes do sexo masculino, com m&#233;dia de idade de 65,4 &#177; 10,9 anos, sendo 20,0% acima dos 75 anos. O quadro cl&#237;nico confirmado com mais frequ&#234;ncia foi o de s&#237;ndrome coronariana aguda (SCA) sem supradesnivelamento do segmento ST (SST) (38,7%). A DAC multiarterial ocorreu em 46,4%, foi indicada ICP em 464 pacientes, sendo tratadas 547 les&#245;es-alvo (tipo B2 ou C, em 86,0%), sendo destas, 14,0% tratadas com stent farmacol&#243;gico. Dentre os IAM com SST, ICP prim&#225;ria foi realizada em 19,0% dos pacientes, sendo que, destes, 77,0% foram transferidos dos hospitais de origem tardiamente (ICP tardia) e n&#227;o receberam trombol&#237;tico pr&#233;vio, e 4,0% realizaram ICP de resgate. Foi obtido sucesso angiogr&#225;fico em 94,2% das ICPs. Aconteceu &#243;bito em 5,6% dos pacientes, tendo estes uma m&#233;dia de idade de 75,2 &#177; 10,2 anos. CONCLUS&#195;O: Observamos predom&#237;nio de idosos (estando 20,1% &gt; 75 anos) e do sexo masculino. Dos fatores de risco para DAC, os mais frequentes foram hipertens&#227;o arterial sist&#234;mica e dislipidemia. Ocorreu predom&#237;nio da SCA. A idade &gt; 75 anos, DAC multiarterial e a insufici&#234;ncia renal cr&#244;nica foram os preditores de &#243;bito intra-hospitalar.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Doen&#231;a da art&#233;ria coron&#225;ria</kwd>
        <kwd>idoso</kwd>
        <kwd>cateterismo card&#237;aco</kwd>
        <kwd>perfil de impacto da doen&#231;a</kwd>
        <kwd>fatores de risco</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>17</day>
        <month>09</month>
        <year>2010</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>ARTIGO ORIGINAL </p>
    <p> ANGIOPLASTIA COM E SEM STENT </p>
    <p>
      <bold>Perfil cl&#237;nico-angiogr&#225;fico na doen&#231;a arterial coronariana: desfecho hospitalar com &#234;nfase nos muito idosos</bold>
    </p>
    <p>
      <bold>Micheli Zanotti Galon<sup>I</sup>; George C&#233;sar Ximenes Meireles<sup>I</sup>; S&#233;rgio Kreimer<sup>I</sup>; Gilberto Guilherme Ajjar Marchiori<sup>I</sup>; Desid&#233;rio Favarato<sup>II</sup>; Jo&#227;o Aparecido Pimenta de Almeida<sup>I</sup>; Lorena Squassante Capeline<sup>I</sup></bold>
    </p>
    <p><sup>I</sup>Hospital do Servidor P&#250;blico Estadual, S&#227;o Paulo, SP - Brasil </p>
    <p><sup>II</sup>Instituto do Cora&#231;&#227;o - HC/FMUSP, S&#227;o Paulo, SP - Brasil</p>
    <p>
      <xref ref-type="corresp" rid="back">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO: </bold> Conhecer fatores de risco e manifesta&#231;&#245;es cl&#237;nicas da doen&#231;a arterial coronariana (DAC) permite-nos intervir de maneira mais eficaz junto a uma determinada popula&#231;&#227;o. </p>
    <p><bold>OBJETIVO: </bold> Identificar perfis cl&#237;nicos e angiogr&#225;ficos dos pacientes submetidos a cateterismo card&#237;aco, atendidos em um hospital terci&#225;rio e tratados por meio de interven&#231;&#245;es coronarianas percut&#226;neas (ICP). </p>
    <p><bold>M&#201;TODOS: </bold> Casu&#237;stica de 1.282 pacientes submetidos a 1.410 cateterismos card&#237;acos, selecionados de mar/2007-mai/2008 em um banco de dados de um hospital geral para diagn&#243;stico de doen&#231;a arterial coronariana (DAC). Fatores de risco, indica&#231;&#227;o do exame, detalhes t&#233;cnicos da ICP e desfechos intra-hospitalares foram prospectivamente coletados. </p>
    <p><bold>RESULTADOS: </bold> Foram 688 (54,0%) pacientes do sexo masculino, com m&#233;dia de idade de 65,4 &#177; 10,9 anos, sendo 20,0% acima dos 75 anos. O quadro cl&#237;nico confirmado com mais frequ&#234;ncia foi o de s&#237;ndrome coronariana aguda (SCA) sem supradesnivelamento do segmento ST (SST) (38,7%). A DAC multiarterial ocorreu em 46,4%, foi indicada ICP em 464 pacientes, sendo tratadas 547 les&#245;es-alvo (tipo B2 ou C, em 86,0%), sendo destas, 14,0% tratadas com <italic>stent</italic> farmacol&#243;gico. Dentre os IAM com SST, ICP prim&#225;ria foi realizada em 19,0% dos pacientes, sendo que, destes, 77,0% foram transferidos dos hospitais de origem tardiamente (ICP tardia) e n&#227;o receberam trombol&#237;tico pr&#233;vio, e 4,0% realizaram ICP de resgate. Foi obtido sucesso angiogr&#225;fico em 94,2% das ICPs. Aconteceu &#243;bito em 5,6% dos pacientes, tendo estes uma m&#233;dia de idade de 75,2 &#177; 10,2 anos. </p>
    <p><bold>CONCLUS&#195;O: </bold> Observamos predom&#237;nio de idosos (estando 20,1% <underline>&gt;</underline> 75 anos) e do sexo masculino. Dos fatores de risco para DAC, os mais frequentes foram hipertens&#227;o arterial sist&#234;mica e dislipidemia. Ocorreu predom&#237;nio da SCA. A idade <underline>&gt;</underline> 75 anos, DAC multiarterial e a insufici&#234;ncia renal cr&#244;nica foram os preditores de &#243;bito intra-hospitalar.</p>
    <p><bold>Palavras-chave: </bold> Doen&#231;a da art&#233;ria coron&#225;ria, idoso, cateterismo card&#237;aco, perfil de impacto da doen&#231;a, fatores de risco.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>A preval&#234;ncia de doen&#231;a arterial coronariana (DAC) vem aumentando progressivamente em todo o mundo, em consequ&#234;ncia do aumento da expectativa de vida e da sobreviv&#234;ncia aos quadros agudos. Fatos que tamb&#233;m s&#227;o verificados no Brasil<sup>1</sup>.</p>
    <p>As doen&#231;as cardiovasculares apresentam expressiva morbimortalidade na popula&#231;&#227;o idosa. A Organiza&#231;&#227;o Mundial de Sa&#250;de (OMS) considera idosos, nos pa&#237;ses em desenvolvimento, os indiv&#237;duos com 60 ou mais anos e, nos pa&#237;ses desenvolvidos, os indiv&#237;duos com 65 ou mais anos. Nos Estados Unidos, os idosos constituem 13,0% da popula&#231;&#227;o, que respondem por 65,0% das hospitaliza&#231;&#245;es por doen&#231;a card&#237;aca. Cerca de 85,0% das mortes por IAM ocorrem na popula&#231;&#227;o idosa<sup>2,3</sup>.</p>
    <p>Em pacientes idosos, a interven&#231;&#227;o coronariana percut&#226;nea (ICP) &#233; uma estrat&#233;gia de revasculariza&#231;&#227;o mioc&#225;rdica frequentemente utilizada<sup>4,5</sup>. Dados observacionais da d&#233;cada de 90 sugerem que os pacientes idosos s&#227;o um grupo de risco elevado para ICP<sup>6,7</sup>; evoluindo com maior mortalidade quando comparados aos indiv&#237;duos mais jovens.</p>
    <p>Os idosos com s&#237;ndrome coronariana aguda (SCA) geralmente apresentam perfil de risco diferente dos n&#227;o idosos: t&#234;m maior preval&#234;ncia de hipertens&#227;o arterial, diabete melito, infarto do mioc&#225;rdio pr&#233;vio, angina, doen&#231;a vascular perif&#233;rica, acidente vascular encef&#225;lico (AVE), doen&#231;a multiarterial e insufici&#234;ncia card&#237;aca. Por outro lado, apresentam n&#237;veis menos elevados de colesterol e menor preval&#234;ncia de tabagismo. Geralmente, o idoso apresenta-se para o atendimento m&#233;dico mais tardiamente, ap&#243;s o in&#237;cio dos sintomas. No caso das SCA, ao inv&#233;s de dor, frequentemente apresentam os chamados "equivalentes isqu&#234;micos", como dispneia, mal estar, confus&#227;o mental, s&#237;ncope ou edema pulmonar. Ainda em rela&#231;&#227;o aos n&#227;o idosos, os idosos t&#234;m menor eleva&#231;&#227;o das enzimas card&#237;acas e maior ocorr&#234;ncia de SCA sem SST<sup>8</sup>. Nos pacientes acima de 75 anos, a terap&#234;utica mais adequada, com betabloqueador, AAS, anticoagulante e hipolipemiante, &#233; a menos utilizada, assim como fibrinol&#237;ticos e a revasculariza&#231;&#227;o por angioplastia ou por cirurgia<sup>9,10</sup>.</p>
    <p>O objetivo do presente estudo foi avaliar os pacientes com suspeita de DAC, submetidos a cateterismo card&#237;aco e ICP com enfoque especial na popula&#231;&#227;o com 75 anos ou mais, suas caracter&#237;sticas cl&#237;nicas basais, modalidades de apresenta&#231;&#227;o, tratamento m&#233;dico e desfechos intra-hospitalares.</p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>
      <bold>Sele&#231;&#227;o da amostra</bold>
    </p>
    <p>O Hospital do Servidor P&#250;blico Estadual atende pacientes de uma rede de servi&#231;os que compreende a cidade de S&#227;o Paulo e 18 Centros de Assist&#234;ncia M&#233;dico-Ambulatorial (CEAMAS), localizados nas cidades do interior do estado de S&#227;o Paulo. Atualmente, o Instituto de Assist&#234;ncia M&#233;dica ao Servidor P&#250;blico Estadual (IAMSPE) compreende 1.239.287 pessoas agregadas, englobando contribuintes e benefici&#225;rios, sendo o HSPE a refer&#234;ncia para procedimentos de alta complexidade, como o cateterismo card&#237;aco. Os pacientes acima de 70 anos foram os respons&#225;veis por cerca de 30,0% das interna&#231;&#245;es nos &#250;ltimos 7 anos.</p>
    <p>Foram 1.410 cateterismos card&#237;acos realizados em 1.282 pacientes para esclarecimento diagn&#243;stico de DAC e inclu&#237;dos, consecutivamente, em um banco de dados de forma prospectiva de mar/2007-mai/2008, por meio do preenchimento de uma ficha cl&#237;nica utilizada para registrar as informa&#231;&#245;es sobre as caracter&#237;sticas cl&#237;nicas basais, sintomas de apresenta&#231;&#227;o, altera&#231;&#245;es eletrocardiogr&#225;ficas, exames laboratoriais, tratamento m&#233;dico e evolu&#231;&#227;o intra-hospitalar dos pacientes. Para evitar o vi&#233;s de sele&#231;&#227;o, crit&#233;rios de exclus&#227;o n&#227;o foram aplicados e todos os pacientes submetidos a cateterismo card&#237;aco para esclarecimento de DAC neste per&#237;odo foram inclu&#237;dos.</p>
    <p>A pesquisa foi aprovada pela Comiss&#227;o de &#201;tica em Pesquisa do Instituto de Assist&#234;ncia M&#233;dica dos Servidores P&#250;blicos do Estado em concord&#226;ncia com a Declara&#231;&#227;o de Helsinki.</p>
    <p>
      <bold>Caracter&#237;sticas analisadas</bold>
    </p>
    <p>Conforme modalidades de apresenta&#231;&#227;o cl&#237;nica da DAC, os pacientes foram caracterizados como: angina est&#225;vel (AE), SCA sem supradesn&#237;vel do segmento ST (SST), SCA com SST ou equivalente isqu&#234;mico (manifesta&#231;&#245;es at&#237;picas da SCA como dispneia, mal estar, confus&#227;o mental, s&#237;ncope ou edema pulmonar). Os fatores de risco para DAC e suas comorbidades foram documentados, no momento da realiza&#231;&#227;o do cateterismo, atrav&#233;s do preenchimento de um question&#225;rio: diabete melito (se presente, especificado o esquema terap&#234;utico em uso: insulinoterapia, hipoglicemiante oral, dieta); tabagismo; hist&#243;ria familiar para DAC; acidente vascular encef&#225;lico (AVE) / ataque isqu&#234;mico transit&#243;rio (AIT); insufici&#234;ncia renal cr&#244;nica (se presente, esquema terap&#234;utico de hemodi&#225;lise ou tratamento conservador); dislipidemia; antecedentes coronarianos (se IAM, revasculariza&#231;&#227;o do mioc&#225;rdio ou ICP pr&#233;vios).</p>
    <p>As caracter&#237;sticas angiogr&#225;ficas, como extens&#227;o da DAC (caracterizada pelo n&#250;mero de vasos com les&#227;o angiogr&#225;fica maior de que 50,0% - uni, bi ou triarteriais), fluxo TIMI antes da ICP (TIMI 0/1, quando houver aus&#234;ncia ou discreto fluxo distal a les&#227;o-alvo; TIMI 2, quando houver fluxo distal a les&#227;o-alvo de toda coron&#225;ria, por&#233;m lentifiado; TIMI 3, quando houver fluxo distal a les&#227;o-alvo de toda coron&#225;ria compat&#237;vel com a normalidade) e vaso tratado (se coron&#225;ria nativa, enxerto venoso/arterial ou vaso com reestenose) foram documentadas e analisadas.</p>
    <p>
      <bold>Cateterismo card&#237;aco e interven&#231;&#227;o coronariana percut&#226;nea</bold>
    </p>
    <p>As ICP foram realizadas de acordo com as t&#233;cnicas habituais e conforme as orienta&#231;&#245;es das diretrizes vigentes<sup>11-13</sup>.</p>
    <p>O sucesso angiogr&#225;fico e do procedimento<sup>11</sup> foi assim definido: 1) angiogr&#225;fico: redu&#231;&#227;o da estenose-alvo para um di&#226;metro de estenose &lt; 30,0%, com manuten&#231;&#227;o ou restabelecimento do fluxo TIMI 3, avaliado pela angiografia coronariana quantitativa; 2) do procedimento: obten&#231;&#227;o de sucesso angiogr&#225;fico e aus&#234;ncia de complica&#231;&#245;es cl&#237;nicas maiores (morte, IAM com SST e cirurgia de revasculariza&#231;&#227;o mioc&#225;rdica de emerg&#234;ncia). A defini&#231;&#227;o de IAM ap&#243;s um procedimento leva em considera&#231;&#227;o o desenvolvimento de novas ondas Q e/ou a eleva&#231;&#227;o da CK-MB (&gt; tr&#234;s vezes seu valor basal), com ou sem a presen&#231;a de precordialgia associada.</p>
    <p>As les&#245;es coronarianas foram diferenciadas em A, B1, B2 e C<sup>11</sup>; conforme a classifica&#231;&#227;o do <italic>American College of Cardiology</italic> e <italic>American Heart Association</italic>. As caracter&#237;sticas de alto risco (tipo C) foram: comprimento da les&#227;o &gt; 20 mm, calcifica&#231;&#227;o maci&#231;a, tortuosidade excessiva do segmento proximal, segmento-alvo com angula&#231;&#227;o extrema (&gt; 90 graus), oclus&#227;o cr&#244;nica em ponta romba, impossibilidade de prote&#231;&#227;o de ramo lateral significativo (<underline>&gt;</underline> 2,5 mm) e esten&#243;tico (&gt; 50%), enxertos venosos degenerados.</p>
    <p>
      <bold>Desfechos intra-hospitalares</bold>
    </p>
    <p>Os pacientes foram acompanhados durante a interna&#231;&#227;o hospitalar, com a inten&#231;&#227;o de evidenciar complica&#231;&#245;es associadas aos procedimentos tanto diagn&#243;sticos como terap&#234;uticos, sendo nestes mais frequentes. As complica&#231;&#245;es categorizadas como maiores foram morte, infarto, RM de urg&#234;ncia e AVE (perda de fun&#231;&#227;o neurol&#243;gica de causa vascular que dura mais de 24 horas). As complica&#231;&#245;es menores foram: complica&#231;&#245;es no local de acesso, insufici&#234;ncia renal secund&#225;ria &#224; nefropatia induzida pelo contraste (aumento relativo de 25-50,0% ou absoluto de 0,5 mg/dl da creatinina basal ap&#243;s exposi&#231;&#227;o ao contraste), rea&#231;&#245;es adversas ao contraste radiol&#243;gico, AIT (<italic>d&#233;ficit</italic> neurol&#243;gico focal de in&#237;cio s&#250;bito com dura&#231;&#227;o menor do que 24 horas, de origem presumidamente vascular e restrito a uma &#225;rea do c&#233;rebro, ou do olho, irrigada por uma art&#233;ria espec&#237;fica)<sup>14</sup>.</p>
    <p>As medica&#231;&#245;es utilizadas durante a interna&#231;&#227;o foram prescritas pelo m&#233;dico respons&#225;vel, sendo documentadas atrav&#233;s do preenchimento da ficha cl&#237;nica, enfatizando: heparinas fracionadas e de baixo peso molecular, tirofiban, AAS, clopidogrel, ticlopidina, nitrato, betabloqueador, bloqueador de canal de c&#225;lcio, inibidor da enzima de convers&#227;o de angiotensina, nitrato, insulina, hipoglicemiante oral<sup>15</sup>.</p>
    <p>
      <bold>2.5. An&#225;lise estat&#237;stica</bold>
    </p>
    <p>Um total de 1.282 pacientes submetidos a 1.410 cateterismos card&#237;acos foram avaliados para esclarecimento diagn&#243;stico de DAC, e terap&#234;utico para tratamento de estenoses coronarianas, de acordo com os crit&#233;rios de inclus&#227;o e exclus&#227;o.</p>
    <p>As vari&#225;veis quantitativas foram apresentadas como m&#233;dias e desvios-padr&#227;o e as frequ&#234;ncias absolutas e relativas &#224;s vari&#225;veis qualitativas foram calculadas.</p>
    <p>Para comparar as associa&#231;&#245;es entre as vari&#225;veis cl&#237;nicas e angiogr&#225;ficas e a ocorr&#234;ncia de &#243;bito, foram utilizados os testes do quiquadrado ou teste exato de Fisher. As idades foram divididas em tr&#234;s faixas et&#225;rias (&lt; 60 anos, 60 - 74 anos e <underline>&gt;</underline> 75 anos).</p>
    <p>Para comparar as distribui&#231;&#245;es do <italic>clearance</italic> de creatinina entre os pacientes menores de 75 anos ou com 75 anos ou mais foi utilizada a ANOVA n&#227;o param&#233;trica Kruskal-Wallis.</p>
    <p>Para se estudar as correla&#231;&#245;es cl&#237;nicas e angiogr&#225;ficas e &#243;bito, de forma multivariada, o modelo de regress&#227;o log&#237;stica com processo de sele&#231;&#227;o de vari&#225;veis <italic>stepwise</italic> foi utilizado.</p>
    <p>O n&#237;vel de signific&#226;ncia usado foi de 5,0%.</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>An&#225;lise global da popula&#231;&#227;o estudada:</p>
    <p>No per&#237;odo estudado, 1.410 cateterismos card&#237;acos foram realizados em 1.282 pacientes para esclarecimento diagn&#243;stico de DAC. A <xref ref-type="table" rid="t1">Tabela 1</xref> discrimina as principais caracter&#237;sticas cl&#237;nicas basais da popula&#231;&#227;o estudada. Foram 688 (54,0%) pacientes do sexo masculino, com m&#233;dia de idade de 65,4 anos (&#177; 10,9), sendo 20,1% acima dos 75 anos. Dentre os fatores de risco cl&#225;ssicos para DAC, os mais frequentes foram a hipertens&#227;o arterial sist&#234;mica e a dislipidemia. A diabete melito esteve presente em 31,6% dos pacientes.</p>
    <table-wrap id="t1">
      <graphic xlink:href="1678-4170-abc-95-04-0422-00127-gt01.jpg"/></table-wrap>
    <p>O quadro cl&#237;nico confirmado que mais desencadeou os cateterismos foi o de SCA sem SST (38,7%). Dentre os IAM com SST, a ICP prim&#225;ria foi realizada em apenas 19,0%; 77,0% foram transferidos dos hospitais de origem tardiamente (ICP tardia) e n&#227;o receberam trombol&#237;tico pr&#233;vio, 4,0% realizaram ICP de resgate (<xref ref-type="fig" rid="aop12310g01">Gr&#225;fico 1</xref>). Dentre os pacientes que n&#227;o foram encaminhados para ICP prim&#225;ria, apenas 12,0% dos pacientes receberam trombol&#237;tico.</p>
    <p content-type="asset">
      <fig id="aop12310g01">
        <graphic xlink:href="1678-4170-abc-95-04-0422-00127-gf01.jpg"/></fig>
    </p>
    <p>Doen&#231;a arterial coronariana multiarterial ocorreu em 46,4% das coronariografias, sendo indicada ICP em 464 pacientes e tratadas 547 les&#245;es-alvo (tipo B2 ou C em 86,6%), localizadas na sua maioria nos vasos nativos (94,7%) e tratados com <italic>stents</italic>, sendo 14,6% com <italic>stent</italic> farmacol&#243;gico (<xref ref-type="table" rid="t2">Tabela 2</xref>).</p>
    <table-wrap id="t2">
      <graphic xlink:href="1678-4170-abc-95-04-0422-00127-gt02.jpg"/></table-wrap>
    <p>O sucesso do procedimento foi obtido em 94,2% das ICPs. Quando analisados por quadro cl&#237;nico, os pacientes com SCA sem SST e os com SST submetidos &#224; angioplastia dentro das primeiras 12 horas apresentaram sucesso em 97,1%, enquanto que os pacientes com SCA com SST tratados tardiamente (&gt; 24 horas) e que mantinham evid&#234;ncia cl&#237;nica de isquemia, como angina p&#243;s-infarto, edema agudo de pulm&#227;o atribu&#237;do &#224; isquemia, dentre outras apresenta&#231;&#245;es consideradas pelo m&#233;dico cl&#237;nico do paciente como sendo resultado de isquemia, apresentaram sucesso em 90,4%. Entre os pacientes com angina est&#225;vel e manifesta&#231;&#245;es at&#237;picas de DAC, o sucesso do procedimento foi obtido em 97,2% e 100,0%, respectivamente.</p>
    <p>O IAM ap&#243;s ICP foi observado em 2,8% dos pacientes, dentre estes, um paciente com trombose aguda (primeiras 24 horas ap&#243;s a ICP) de <italic>stent</italic> farmacol&#243;gico (Supralimus 2,5 x 39 mm), possivelmente devido &#224; hipoexpans&#227;o do <italic>stent</italic> em uma por&#231;&#227;o da les&#227;o com intensa calcifica&#231;&#227;o da art&#233;ria. N&#227;o houve necessidade de RM de urg&#234;ncia (<xref ref-type="table" rid="t3">Tabela 3</xref>).</p>
    <table-wrap id="t3">
      <graphic xlink:href="1678-4170-abc-95-04-0422-00127-gt03.jpg"/></table-wrap>
    <p>Dentre os pacientes submetidos &#224; coronariografia, a insufici&#234;ncia renal secund&#225;ria &#224; nefropatia induzida pelo contraste ocorreu em 20 pacientes (1,6%), dos quais um quarto necessitou de di&#225;lise como terap&#234;utica. O sangramento da via de acesso arterial ocorreu em um paciente (via femoral), havendo necessidade de transfus&#227;o sangu&#237;nea. N&#227;o foi observado pseudoaneurisma no local da pun&#231;&#227;o e tamb&#233;m n&#227;o foi observada isquemia do membro inferior ou superior (no caso de procedimento via radial), AVE isqu&#234;mico ou hemorr&#225;gico.</p>
    <p>&#211;bito ap&#243;s ICP ocorreu em 5,2%, m&#233;dia de idade de 75,2 &#177; 10,2 anos. O n&#250;mero de vasos acometidos por les&#245;es graves apresentou associa&#231;&#227;o com a mortalidade intra-hospitalar: um, dois, tr&#234;s vasos ou tronco de coron&#225;ria esquerda apresentaram a mortalidade de 0,54%, 3,33% e 3,41%, respectivamente (p = 0,0005).</p>
    <p>As medica&#231;&#245;es mais utilizadas pelos pacientes no momento da realiza&#231;&#227;o do cateterismo (<xref ref-type="table" rid="t4">Tabela 4</xref>) foram AAS (65,7%) e estatina (52,3%). Globalmente, os pacientes submetidos &#224; ICP receberam terapia antiplaquet&#225;ria dupla (AAS e clopidogrel) ap&#243;s a realiza&#231;&#227;o da angioplastia (97,3%).</p>
    <table-wrap id="t4">
      <graphic xlink:href="1678-4170-abc-95-04-0422-00127-gt04.jpg"/></table-wrap>
    <p>O tempo de interna&#231;&#227;o hospitalar foi maior nos pacientes com quadro cl&#237;nico de SCA (13,7 dias).</p>
    <p>
      <bold>An&#225;lise comparativa entre pacientes com idade menor que 75 anos e maior ou igual a 75 anos</bold>
    </p>
    <p>Os pacientes de 75 anos ou mais apresentaram <italic>clearance</italic> de creatinina (Clcr) menor do que os pacientes menores de 75 anos (42,06 e 68,18 l/min/1,73m<sup>2</sup>; respectivamente; p &lt; 0,00001). Na an&#225;lise comparativa com o g&#234;nero masculino, as pacientes do sexo feminino submetidas a cateterismo card&#237;aco eram mais idosas.</p>
    <p>A mortalidade nos maiores de 75 anos foi maior do que nos menores de 75 anos (5,0% <italic>versus</italic> 1%; p=0,000097), assim como nos com IRC pr&#233;via (5,3% <italic>versus</italic> 1,3%; p = 0,0028), conforme visibilizado na <xref ref-type="table" rid="t5">Tabela 5</xref>. Todos os &#243;bitos foram em pacientes com diagn&#243;stico de SCA (com supra ST = 37,5%; sem supra de ST = 62,5%).</p>
    <table-wrap id="t5">
      <graphic xlink:href="1678-4170-abc-95-04-0422-00127-gt05.jpg"/></table-wrap>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>O presente estudo &#233; o primeiro registro sobre as caracter&#237;sticas cl&#237;nicas e angiogr&#225;ficas da popula&#231;&#227;o de servidores do estado de S&#227;o Paulo submetidos a cateterismos card&#237;acos para esclarecimento diagn&#243;stico de doen&#231;a arterial coronariana e terap&#234;utico para tratamento de estenoses coronarianas no Servi&#231;o de Hemodin&#226;mica e Cardiologia Intervencionista do Hospital do Servidor P&#250;blico Estadual (HSPE) - Francisco Morato de Oliveira (FMO) do IAMSPE.</p>
    <p>A popula&#231;&#227;o atendida no HSPE-FMO do IAMSPE caracteriza-se pela preval&#234;ncia de idosos e os pacientes acima de 70 anos s&#227;o respons&#225;veis por cerca de 30,0% das interna&#231;&#245;es, informa&#231;&#227;o de grande import&#226;ncia posto que tais pacientes s&#227;o frequentemente exclu&#237;dos de ensaios cl&#237;nicos. Podemos tamb&#233;m avaliar a utiliza&#231;&#227;o e a ader&#234;ncia da classe m&#233;dica a modalidades terap&#234;uticas. Com este registro, descrevemos uma popula&#231;&#227;o espec&#237;fica, apresentando o seu perfil e como se tem conduzido a investiga&#231;&#227;o diagn&#243;stica da DAC e o tratamento desta entidade cl&#237;nica &#224; luz das diretrizes recomendadas e de in&#250;meros ensaios cl&#237;nicos.</p>
    <p>Segundo dados da Funda&#231;&#227;o Seade, o n&#250;mero de idosos no Estado de S&#227;o Paulo &#233; 4,3 milh&#245;es e, deste total, 1,9 milh&#227;o &#233; composto por pessoas com 70 anos ou mais de idade (www.seade.org.br). Em 2020, teremos 7,1 milh&#245;es de idosos no estado de S&#227;o Paulo, deste total, 2,9 milh&#245;es constitu&#237;dos por pessoas com 70 anos ou mais. Da&#237; a grande import&#226;ncia de estudos epidemiol&#243;gicos em popula&#231;&#245;es que apresentem preval&#234;ncia de idosos.</p>
    <p>Uma das observa&#231;&#245;es mais importantes foi o grande n&#250;mero de pacientes com SCA sem supra de ST (38,7%) atendidos em um hospital geral, n&#250;mero este compar&#225;vel aos 40,0% de centros de emerg&#234;ncia em cardiologia<sup>16</sup>. A realiza&#231;&#227;o da coronariografia permite a identifica&#231;&#227;o precisa da extens&#227;o e da gravidade das obstru&#231;&#245;es coronarianas, complementa a estratifica&#231;&#227;o progn&#243;stica e a identifica&#231;&#227;o da mais apropriada forma de tratamento (cl&#237;nico, revasculariza&#231;&#227;o percut&#226;nea ou cir&#250;rgica), pela anatomia coronariana desvendada angiograficamente.</p>
    <p>Duas estrat&#233;gias emergem para o tratamento desses enfermos: estrat&#233;gia invasiva precoce, realiza&#231;&#227;o da coronariografia em at&#233; 72 horas; e estrat&#233;gia conservadora, ap&#243;s 72 horas da admiss&#227;o hospitalar<sup>17,18</sup>. Embora n&#227;o haja unanimidade quanto &#224; melhor estrat&#233;gia, as evid&#234;ncias mais recentes apoiam a estrat&#233;gia invasiva precoce. O conjunto desses ensaios &#233; favor&#225;vel &#224; prescri&#231;&#227;o da "estrat&#233;gia invasiva", pois reduziu a mortalidade e a ocorr&#234;ncia de infarto tardio assim como a re-hospitaliza&#231;&#227;o por SCA<sup>18-21</sup>.</p>
    <p>Neste registro, aplicamos a estrat&#233;gia invasiva precoce visando identificar pacientes de mais alto risco, como portadores de DAC multiarterial grave (23,0%) e estenoses no tronco da coron&#225;ria esquerda (2,0%). A despeito dessa conduta, observamos uma demora na indica&#231;&#227;o do cateterismo, sendo o paciente encaminhado para a hemodin&#226;mica muitas vezes apenas quando admitidos na unidade coronariana ou enfermaria de cardiologia, ap&#243;s a avalia&#231;&#227;o feita por um cardiologista. Tal conduta possivelmente se refletiu em um maior per&#237;odo de interna&#231;&#227;o hospitalar.</p>
    <p>Nos pacientes com SCA com SST, o tempo decorrido entre o in&#237;cio da dor e a recanaliza&#231;&#227;o coronariana, qu&#237;mica ou mec&#226;nica, &#233; o fator fundamental para o benef&#237;cio do tratamento, tanto imediato quanto tardio, considerando a rela&#231;&#227;o com a mortalidade e com a morbidade, em pacientes tratados em at&#233; 12 horas do in&#237;cio da dor. Dado preocupante, em rela&#231;&#227;o aos pacientes com tal diagn&#243;stico transferidos de outros hospitais, &#233; o fato dos mesmos n&#227;o receberem a terap&#234;utica de reperfus&#227;o adequada, seja pelo retardo na transfer&#234;ncia ou pela n&#227;o administra&#231;&#227;o de trombol&#237;tico pr&#233;vio (apenas 19,0% de ICP prim&#225;ria nas primeiras 12 horas e 12,0% de trombol&#237;tico neste registro). Tal fato repercutiu no &#237;ndice de sucesso do procedimento como descrito nos resultados, pois os pacientes submetidos &#224; ICP dentro das primeiras 12 horas apresentaram sucesso em 97,1% e os submetidos a ICP tardiamente, 90,4% (ICP foi realizada, pois, conforme o estado cl&#237;nico dos pacientes, havia evid&#234;ncia cl&#237;nica de isquemia mioc&#225;rdica).</p>
    <p>Os estudos demonstraram que a prescri&#231;&#227;o eletiva de ICP para uma art&#233;ria coron&#225;ria oclu&#237;da com o prazo de um a 28 dias, ap&#243;s a ocorr&#234;ncia de IAM em pacientes est&#225;veis, n&#227;o propiciou nenhum benef&#237;cio superior &#224;quele oferecido pela terap&#234;utica cl&#237;nica composta de &#225;cido acetilsalic&#237;lico, betabloqueadores, inibidores da enzima conversora e estatinas, na preserva&#231;&#227;o da fun&#231;&#227;o contr&#225;til do ventr&#237;culo esquerdo e de novos eventos cardiovasculares<sup>22,23</sup>.</p>
    <p>Dados da literatura comprovaram as vantagens da ICP prim&#225;ria, se comparado &#224; fibrin&#243;lise. A ICP prim&#225;ria &#233; capaz de restabelecer o fluxo coron&#225;rio epic&#225;rdico normal (TIMI grau 3) em mais de 90,0% dos pacientes, que &#233; associado a reduzidas taxas de isquemia recorrente e reinfarto, sem o risco da ocorr&#234;ncia de complica&#231;&#245;es hemorr&#225;gicas graves, como AVE<sup>24-26</sup>.</p>
    <p>Grupos de pacientes considerados de alto risco, como os idosos, frequentemente t&#234;m a indica&#231;&#227;o de coronariografia retardada ou evitada, em evidente contradi&#231;&#227;o &#224; literatura<sup>27,28</sup>. Essa estrat&#233;gia priva esses pacientes da possibilidade de tratamento, pois os mesmos teriam maior benef&#237;cio na revasculariza&#231;&#227;o precoce, refletidas nas taxas de mortalidade e/ou reinfarto. Esse comportamento parece n&#227;o ocorrer neste registro, haja vista a m&#233;dia de idade de 65,4 anos (&#177; 10,9) dos pacientes submetidos a cateterismo, sendo 20,1% com 75 anos ou mais.</p>
    <p>Nas SCA, os idosos t&#234;m maior incid&#234;ncia de complica&#231;&#245;es, o que implica na necessidade de tratamento mais intensivo. Entretanto, especialmente naqueles acima de 75 anos, frequentemente a terap&#234;utica mais adequada, com betabloqueador, AAS, anticoagulante e hipolipemiante, n&#227;o &#233; utilizada<sup>9,29</sup>. Durante o per&#237;odo intra-hospitalar, essa diferen&#231;a na prescri&#231;&#227;o medicamentosa n&#227;o foi observada neste registro.</p>
    <p>Nosso estudo constatou que, dentre os pacientes submetidos &#224; ICP, os com 75 anos ou mais tiveram uma mortalidade maior, apesar do sucesso angiogr&#225;fico ter sido similar aos menores de 75 anos. As complica&#231;&#245;es continuam mais frequentes nos pacientes mais velhos; a preval&#234;ncia de insufici&#234;ncia renal p&#243;s-procedimento decorrente da nefropatia induzida pelo contraste foi compat&#237;vel com a da literatura.</p>
    <p>Mehran e cols.<sup>30</sup> avaliaram os v&#225;rios fatores de risco para nefropatia induzida por contraste, determinando um escore de estratifica&#231;&#227;o de risco para o desenvolvimento de insufici&#234;ncia renal aguda ap&#243;s ICP. Considerando que a popula&#231;&#227;o idosa apresenta reduzida taxa de filtra&#231;&#227;o glomerular, &#233; de se presumir que a nefropatia induzida pelo contraste ocorreria mais frequentemente neste grupo de indiv&#237;duos. Embora esse evento possa ser previsto, a morbidade relacionada ainda &#233; significativa, fazendo com que esse risco seja considerado na indica&#231;&#227;o do procedimento. Em casos de pacientes com alta probabilidade para nefropatia induzida pelo contraste, medidas profil&#225;ticas, como hidrata&#231;&#227;o, uso de contraste de baixo peso molecular e medidas alternativas, como hidrata&#231;&#227;o com bicarbonato<sup>31</sup> e N-acetilciste&#237;na<sup>32</sup>; devem ser consideradas.</p>
    <p>O aumento do risco de desenvolver insufici&#234;ncia renal aguda tamb&#233;m tem sido reportado em pacientes com insufici&#234;ncia renal cr&#244;nica com SCA sem SST submetidos &#224; ICP precoce<sup>33,34</sup>. Nesse grupo de pacientes, a profilaxia de insufici&#234;ncia renal aguda pode ser realizada e, normalmente, &#233; poss&#237;vel obter a estabilidade cl&#237;nica dos pacientes antes da interven&#231;&#227;o, diferentemente dos pacientes com SCA com SST submetidos &#224; ICP prim&#225;ria, nos quais n&#227;o &#233; poss&#237;vel a realiza&#231;&#227;o de hidrata&#231;&#227;o pr&#233;via e a instabilidade hemodin&#226;mica &#233; mais frequente.</p>
    <p>Nosso registro identificou que pacientes com insufici&#234;ncia renal cr&#244;nica tiveram maior mortalidade intra-hospitalar, apesar de realizarmos preparo renal e evitarmos a estrat&#233;gia invasiva precoce nestes pacientes.</p>
    <p>Pacientes idosos s&#227;o mais frequentemente multiarteriais. O tempo de sobrevida diminui com o envolvimento de vasos adicionais, com o comprometimento da descendente anterior e com disfun&#231;&#227;o ventricular esquerda<sup>35,36</sup>.</p>
    <p>Nossa an&#225;lise demonstra que tanto pacientes idosos quanto mais jovens podem se beneficiar da ICP, com altos &#237;ndices de sucesso, fato que tamb&#233;m tem sido observado por outros autores<sup>37,38</sup>. A idade n&#227;o pode ser considerada um fator limitante aos procedimentos percut&#226;neos.</p>
    <p>
      <bold>Conclus&#227;o</bold>
    </p>
    <p>Na popula&#231;&#227;o estudada, observamos predom&#237;nio de idosos, sendo 20,1% acima dos 75 anos e do sexo masculino. Dentre os fatores de risco para DAC, os mais frequentes foram hipertens&#227;o arterial sist&#234;mica e dislipidemia. Ocorreu o predom&#237;nio da s&#237;ndrome coronariana aguda. A idade maior ou igual a 75 anos, DAC multiarterial e a insufici&#234;ncia renal cr&#244;nica foram os preditores de &#243;bito intra-hospitalar nos pacientes submetidos &#224; ICP.</p>
    <p>Os pacientes com idade maior ou igual a 75 anos apresentaram perfil cl&#237;nico/angiogr&#225;fico de maior risco e taxa de sucesso do procedimento semelhantes aos de pacientes mais jovens, demonstrando ser a ICP uma t&#233;cnica segura e eficaz neste grupo de pacientes.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte de disserta&#231;&#227;o de Mestrado de Micheli Zanotti Galon pelo Instituto de Assist&#234;ncia M&#233;dica ao Servidor P&#250;blico Estadual.</p>
    <p>
      <fn id="back" fn-type="corresp">
        <p>Correspond&#234;ncia:</p>
        <p> Micheli Zanotti Galon </p>
        <p> R. Francisco Leit&#227;o, N 205, Apto 42 - Pinheiros </p>
        <p> 05414-020 - S&#227;o Paulo, SP - Brasil </p>
        <p> E-mail: </p>
        <p>
          <email xlink:href="micheligalon@yahoo.com.br">micheligalon@yahoo.com.br</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 10/11/09; revisado recebido em 25/03/10; aceito em 09/04/10.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <mixed-citation>1. Minist&#233;rio da Sa&#250;de. Datasus. Morbidade e mortalidade no Brasil por doen&#231;as cardiovasculares. [acesso em 2007 dez 19]. Dispon&#237;vel em <ext-link ext-link-type="uri" xlink:href="http://www.datasus.gov.br">http://www.datasus.gov.br</ext-link>.</mixed-citation>
        <element-citation publication-type="book">
          <source>Datasus: Morbidade e mortalidade no Brasil por doen&#231;as cardiovasculares</source>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. US Department    of Health and Human Services. Advance report of final mortality statistics.    Washington: Public Health Service; 1990.</mixed-citation>
        <element-citation publication-type="book">
          <source>Advance report of final mortality statistics</source>
          <date>
            <year>1990</year>
          </date>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation>3. US Department of Health and Human Services. National hospital discharge survey. Washington: Public Health Service; 1987.</mixed-citation>
        <element-citation publication-type="other">
          <date>
            <year>1987</year>
          </date>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Fraker TD Jr,    Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, Daley J, et al. 2007 chronic angina    focused update of the ACC/AHA 2002 guidelines for the management of patients    with chronic stable angina: a report of the American College of Cardiology/American    Heart Association Task Force on Practice Guidelines Writing Group to develop    the focused update of the 2002 guidelines for the management of patients with    chronic stable angina. J Am Coll Cardiol. 2007; 50 (23): 2264-74.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>2264</fpage>
          <lpage>74</lpage>
          <issue>23</issue>
          <volume>50</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Fraker TD</surname>
              <given-names>Jr</given-names>
            </name>
            <name>
              <surname>Fihn</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Gibbons</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Abrams</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chatterjee</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Daley</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Alexander KP,    Anstrom KJ, Muhlbaier LH, Grosswald RD, Smith PK, Jones RH, et al. Outcomes    of cardiac surgery in patients &gt; or = 80 years: results from the National    Cardiovascular Network. J Am Coll Cardiol. 2000; 35 (3): 731-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Outcomes of cardiac surgery in patients &gt; or = 80 years: results from the National Cardiovascular Network</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>731</fpage>
          <lpage>8</lpage>
          <issue>3</issue>
          <volume>35</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Alexander</surname>
              <given-names>KP</given-names>
            </name>
            <name>
              <surname>Anstrom</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Muhlbaier</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Grosswald</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>RH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Thompson RC,    Holmes DR Jr, Gersh BJ, Mock MB, Bailey KR. Percutaneous transluminal coronary    angioplasty in the elderly: early and long-term results. J Am Coll Cardiol.    1991; 17 (6): 1245-50.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Percutaneous transluminal coronary angioplasty in the elderly: early and long-term results</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>1991</year>
          </date>
          <fpage>1245</fpage>
          <lpage>50</lpage>
          <issue>6</issue>
          <volume>17</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Thompson</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Holmes DR</surname>
              <given-names>Jr</given-names>
            </name>
            <name>
              <surname>Gersh</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Mock</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Bailey</surname>
              <given-names>KR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Wennberg DE,    Makenka DJ, Sengupta A, Lucas FL, VaitkusPT, Quinton H, et al. Percutaneous    transluminal coronary angioplasty in the elderly: epidemiology, clinical risk    factors, and in-hospital outcomes. The Northern New England Cardiovascular Disease    Study Group. Am Heart J. 1999; 137 (4 pt 1): 639-45.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Percutaneous transluminal coronary angioplasty in the elderly: epidemiology, clinical risk factors, and in-hospital outcomes. The Northern New England Cardiovascular Disease Study Group</article-title>
          <source>Am Heart J</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>639</fpage>
          <lpage>45</lpage>
          <volume>137</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Wennberg</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Makenka</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Sengupta</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lucas</surname>
              <given-names>FL</given-names>
            </name>
            <name>
              <surname>Vaitkus</surname>
              <given-names>PT</given-names>
            </name>
            <name>
              <surname>Quinton</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Keller NM, Feit    F. Coronary artery disease in the geriatric population. Prog Cardiovasc Dis.    1996; 38 (5): 407-18.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Coronary artery disease in the geriatric population</article-title>
          <source>Prog Cardiovasc Dis</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>407</fpage>
          <lpage>18</lpage>
          <issue>5</issue>
          <volume>38</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Keller</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Feit</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Randomised trial    of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases    of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International    Study of Infarct Survival) Collaborative Group. Lancet. 1988; 2 (8607): 349-60.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group</article-title>
          <source>Lancet</source>
          <date>
            <year>1988</year>
          </date>
          <fpage>349</fpage>
          <lpage>60</lpage>
          <issue>8607</issue>
          <volume>2</volume>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Sokolyk S,    Tresch D. Treatment of myocardial infarction in elderly patients. Compr Ther.    1994; 20 (10): 537-44.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Treatment of myocardial infarction in elderly patients</article-title>
          <source>Compr Ther</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>537</fpage>
          <lpage>44</lpage>
          <issue>10</issue>
          <volume>20</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sokolyk</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tresch</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. King SB 3rd,    Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA, Williams DO, et al. 2007    Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary    Intervention: a report of the American College of Cardiology/American Heart    Association Task Force on Practice Guidelines: 2007 Writing Group to Review    New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous    Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation.    2008; 117 (2): 261-95.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee</article-title>
          <source>Circulation</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>261</fpage>
          <lpage>95</lpage>
          <issue>2</issue>
          <volume>117</volume>
          <person-group person-group-type="author">
            <name>
              <surname>King SB</surname>
              <given-names>3rd</given-names>
            </name>
            <name>
              <surname>Smith SC</surname>
              <given-names>Jr</given-names>
            </name>
            <name>
              <surname>Hirshfeld JW</surname>
              <given-names>Jr</given-names>
            </name>
            <name>
              <surname>Jacobs</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Morrison</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>DO</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Silber S, Albertsson    P, Aviles FF, Camici PG, Colombo A, Hamm C, et al. Guidelines for percutaneous    coronary interventions. The Task Force for Percutaneous Coronary Interventions    of the European Society of Cardiology. Eur Heart J. 2005; 26 (8): 804-47.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Guidelines for percutaneous coronary interventions: The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>804</fpage>
          <lpage>47</lpage>
          <issue>8</issue>
          <volume>26</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Silber</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Albertsson</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Aviles</surname>
              <given-names>FF</given-names>
            </name>
            <name>
              <surname>Camici</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Colombo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hamm</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Smith SC Jr,    Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB 3rd, et al. ACC/AHA/SCAI    2005 guideline update for percutaneous coronary intervention: a report of the    American College of Cardiology/American Heart Association Task Force on Practice    Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous    Coronary Intervention). Circulation. 2006; 113 (7): e166-286.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention)</article-title>
          <source>Circulation</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>e166</fpage>
          <lpage>286</lpage>
          <issue>7</issue>
          <volume>113</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Smith SC</surname>
              <given-names>Jr</given-names>
            </name>
            <name>
              <surname>Feldman</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Hirshfeld JW</surname>
              <given-names>Jr</given-names>
            </name>
            <name>
              <surname>Jacobs</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Kern</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>King SB</surname>
              <given-names>3rd</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Steg PG, Goldeberg    RJ, Gore JM, Fox KA, Eagle KA, Flather MD, et al. Baseline characteristics,    management practices, and in-hospital outcomes of patients hospitalized with    acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE).    Am J Cardiol. 2002; 90 (4): 358-63.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE)</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>358</fpage>
          <lpage>63</lpage>
          <issue>4</issue>
          <volume>90</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Steg</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Goldeberg</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Gore</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Fox</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Eagle</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Flather</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Caro JJ, Magliaccio-Walle    K. for the CAPRA (CAPRIE Actual Practice Rates Analysis) Study Group. Generalizing    the results of clinical trials to actual practice: the example of clopidogrel    therapy for the prevention of vascular events. Am J Med. 1999; 107 (6): 568-72.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>for the CAPRA (CAPRIE Actual Practice Rates Analysis) Study Group: Generalizing the results of clinical trials to actual practice: the example of clopidogrel therapy for the prevention of vascular events</article-title>
          <source>Am J Med</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>568</fpage>
          <lpage>72</lpage>
          <issue>6</issue>
          <volume>107</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Caro</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Magliaccio-Walle</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Santos ES,    Minuzzo L,Pereira MP, Castillo MT, Palacio MA, Ramos RF, et al. Registro de    s&#237;ndrome coronariana em um centro de emerg&#234;ncias em cardiologia.    Arq Bras Cardiol. 2006; 87 (5): 597-602.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Registro de s&#237;ndrome coronariana em um centro de emerg&#234;ncias em cardiologia</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>597</fpage>
          <lpage>602</lpage>
          <issue>5</issue>
          <volume>87</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Santos</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Minuzzo</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Castillo</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Palacio</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Ramos</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Bucher HC,    Hengstler P, Schindler C, Guyatt GH. Percutaneous transluminal coronary angioplasty    versus medical treatment for non-acute coronary heart disease: meta-analysis    of randomized controlled trials. Br Med J. 2000; 321 (7253): 73-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomized controlled trials</article-title>
          <source>Br Med J</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>73</fpage>
          <lpage>7</lpage>
          <issue>7253</issue>
          <volume>321</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bucher</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Hengstler</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Schindler</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Guyatt</surname>
              <given-names>GH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Bassand JP,    Hamm CW, Ardissino D, Boersma E, Budaj A, Fern&#225;ndez-Avil&#233;s F,    et al. Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute    Coronary Syndromes of European Society of Cardiology. Guidelines for the diagnosis    and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart    J. 2007; 28 (13): 1598-660.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology: Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>1598</fpage>
          <lpage>660</lpage>
          <issue>13</issue>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bassand</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Hamm</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Ardissino</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Boersma</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Budaj</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fern&#225;ndez-Avil&#233;s</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Anderson JL,    Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, et al. American College    of Cardiology; American Heart Association Task Force on Practice Guidelines    (Writing Committee to Revise the 2002 Guidelines for the Management of Patients    With Unstable Angina/Non-ST-Elevation Myocardial Infarction). ACC/AHA 2007 guidelines    for the management of patients with unstable angina/non-ST-Elevation myocardial    infarction: a report of the American College of Cardiology/American Heart Association    Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines    for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial    Infarction) developed in collaboration with the American College of Emergency    Physicians, the Society for Cardiovascular Angiography and Interventions, and    the Society of Thoracic Surgeons endorsed by the American Association of Cardiovasculr    and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.    J Am Coll Cardiol. 2007; 50 (7): e1-e157.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction): ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovasculr and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>e1</fpage>
          <lpage>e157</lpage>
          <issue>7</issue>
          <volume>50</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Antman</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Bridges</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Califf</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Casey DE</surname>
              <given-names>Jr</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Nicolau JC,    Timerman A, Piegas LS, Marin-Neto JA, Rassi A Jr. Guidelines for unstable angina    and non-ST-segment elevation myocardial infarction of the Brazilian Society    of Cardiology (II Edition, 2007). Arq Bras Cardiol. 2007; 89 (4): e89-e131.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Guidelines for unstable angina and non-ST-segment elevation myocardial infarction of the Brazilian Society of Cardiology (II Edition, 2007)</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>e89</fpage>
          <lpage>e131</lpage>
          <issue>4</issue>
          <volume>89</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Nicolau</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Timerman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Piegas</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Marin-Neto</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Rassi A</surname>
              <given-names>Jr</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Bavry AA, Kumbhani    DJ, Rassi AN, Bhatt DL, Askari AT. Benefit of early invasive therapy in acute    coronary syndromes: a meta-analysis of contemporary randomized clinical trials.    J Am Coll Cardiol. 2006; 48 (7): 1319-25.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>1319</fpage>
          <lpage>25</lpage>
          <issue>7</issue>
          <volume>48</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bavry</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Kumbhani</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Rassi</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Bhatt</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Askari</surname>
              <given-names>AT</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Dzav&#237;k    V, Buller CE, Lamas GA, Rankin JM, Mancini GB, Cantor WJ, et al. TOSCA-2 Investigators.    Randomized trial of percutaneous coronary intervention for subacute infarct-related    coronary artery occlusion to achieve long-term patency and improve ventricular    function: the Total Occlusion Study of Canada (TOSCA)-2 trial. Circulation.    2006; 114 (23): 2449-57.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>TOSCA-2 Investigators: Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada (TOSCA)-2 trial</article-title>
          <source>Circulation</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>2449</fpage>
          <lpage>57</lpage>
          <issue>23</issue>
          <volume>114</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Dzav&#237;k</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Buller</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Lamas</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Rankin</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Mancini</surname>
              <given-names>GB</given-names>
            </name>
            <name>
              <surname>Cantor</surname>
              <given-names>WJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Hochman JS,    Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ, et al. (Occluded Artery    Trial Investigators). Coronary intervention for persistent occlusion after myocardial    infarction. N Engl J Med. 2006; 355 (23): 2395-407.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>(Occluded Artery Trial Investigators): Coronary intervention for persistent occlusion after myocardial infarction</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>2395</fpage>
          <lpage>407</lpage>
          <issue>23</issue>
          <volume>355</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hochman</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Lamas</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Buller</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Dzavik</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Reynolds</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Abramsky</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Van de WF,    Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA, et al. Management of acute    myocardial infarction in patients presenting with STsegment elevation. The Task    Force on the Management of Acute Myocardial Infarction of the European Society    of Cardiology. Eur Heart J. 2003; 24 (1): 28-66.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Management of acute myocardial infarction in patients presenting with STsegment elevation: The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>28</fpage>
          <lpage>66</lpage>
          <issue>1</issue>
          <volume>24</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Van de</surname>
              <given-names>WF</given-names>
            </name>
            <name>
              <surname>Ardissino</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Betriu</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cokkinos</surname>
              <given-names>DV</given-names>
            </name>
            <name>
              <surname>Falk</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Fox</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Bertrand ME,    Simoons ML, Fox KA, Wallentin LC, Hamm CW, McFadden E, et al. Management of    acute coronary syndromes in patients presenting without persistent ST-segment    elevation. Eur Heart J. 2002; 23 (23): 1809-40.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>1809</fpage>
          <lpage>40</lpage>
          <issue>23</issue>
          <volume>23</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bertrand</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Simoons</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Fox</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Wallentin</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Hamm</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>McFadden</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. Braunwald E,    Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA 2002    guideline update for the management of patients with unstable angina and non-ST-segment    elevation myocardial infarction-summary article: a report of the American College    of Cardiology/American Heart Association task force on practice guidelines (Committee    on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2002;    40 (7): 1366-74.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina)</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>1366</fpage>
          <lpage>74</lpage>
          <issue>7</issue>
          <volume>40</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Braunwald</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Antman</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Beasley</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Califf</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Cheitlin</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Hochman</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <mixed-citation>27. Spencer FA,    Goldberg RJ, Frederick PD, Malmgren J, Becker RC, Gore JM. Age and the utilization    of cardiac catheterization following uncomplicated first acute myocardial infarction    treated with thrombolytic therapy (The Second National Registry of Myocardial    Infarction [NRMI-2]). Am J Cardiol. 2001; 88 (2): 107-11.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Age and the utilization of cardiac catheterization following uncomplicated first acute myocardial infarction treated with thrombolytic therapy (The Second National Registry of Myocardial Infarction [NRMI-2])</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>107</fpage>
          <lpage>11</lpage>
          <issue>2</issue>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Spencer</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Goldberg</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Frederick</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Malmgren</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Becker</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Gore</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B28">
        <mixed-citation>28. Pilote L, Miller    DP, Califf RM, Rao JS, Weaver WD, Topol EJ. Determinants of the use of coronary    angiography and revascularization after thrombolysis for acute myocardial infarction.    N Engl J Med. 1996; 335 (16): 1198-205.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>1198</fpage>
          <lpage>205</lpage>
          <issue>16</issue>
          <volume>335</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pilote</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Califf</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Weaver</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Topol</surname>
              <given-names>EJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B29">
        <mixed-citation>29. Sokolyk S,    Tresch D. Treatment of myocardial infarction in elderly patients. Compr Ther.    1994; 20 (10): 537-44.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Treatment of myocardial infarction in elderly patients</article-title>
          <source>Compr Ther</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>537</fpage>
          <lpage>44</lpage>
          <issue>10</issue>
          <volume>20</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sokolyk</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tresch</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B30">
        <mixed-citation>30. Mehran R, Aymong    ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction    of contrast-induced nephropathy after percutaneous coronary intervention: development    and initial validation. J Am Coll Cardiol. 2004; 44 (7): 1393-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>1393</fpage>
          <lpage>9</lpage>
          <issue>7</issue>
          <volume>44</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Mehran</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Aymong</surname>
              <given-names>ED</given-names>
            </name>
            <name>
              <surname>Nikolsky</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Lasic</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Iakovou</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Fahy</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B31">
        <mixed-citation>31. Briguori C,    Airoldi F, D'Andrea D, Bonizzoni E, Morici N, Focaccio A, et al. Renal Insufficiency    Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison    of 3 preventive strategies. Circulation. 2007; 115 (10): 1211-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies</article-title>
          <source>Circulation</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>1211</fpage>
          <lpage>7</lpage>
          <issue>10</issue>
          <volume>115</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Briguori</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Airoldi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>D'Andrea</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bonizzoni</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Morici</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Focaccio</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B32">
        <mixed-citation>32. Azmus AD, Gottschall    C, Manica A, Manica J, Duro K, Frey M, et al. Effectiveness of acetylcysteine    in prevention of contrast nephropathy. J Invasive Cardiol. 2005; 17 (2): 80-4.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effectiveness of acetylcysteine in prevention of contrast nephropathy</article-title>
          <source>J Invasive Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>80</fpage>
          <lpage>4</lpage>
          <issue>2</issue>
          <volume>17</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Azmus</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Gottschall</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Manica</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Manica</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Duro</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Frey</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B33">
        <mixed-citation>33. Wison S, Foo    K, Cunningham J, Cooper J, Deaner A, Knight C, et al. Renal function and risk    stratification in acute coronary syndromes. Am J Cardiol. 2003; 91 (9): 1051-4.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Renal function and risk stratification in acute coronary syndromes</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>1051</fpage>
          <lpage>4</lpage>
          <issue>9</issue>
          <volume>91</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Wison</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Foo</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Cunningham</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Deaner</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Knight</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B34">
        <mixed-citation>34. Freeman RV,    Mehta RH, Al Badr W, Cooper JV, Kline-Rogers E, Eagle KA. Influence of concurrent    renal dysfunction on outcomes of patients with acute coronary syndromes and    implications of the use of glycoprotein IIb/IIIa inhibitors. J Am Coll Cardiol.    2003; 41 (5): 718-24.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>718</fpage>
          <lpage>24</lpage>
          <issue>5</issue>
          <volume>41</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Freeman</surname>
              <given-names>RV</given-names>
            </name>
            <name>
              <surname>Mehta</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Al Badr</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>JV</given-names>
            </name>
            <name>
              <surname>Kline-Rogers</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Eagle</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B35">
        <mixed-citation>35. Califf RM,    Armstrong PW, Carver JR, D'Agostino RB, Strauss WE. 27th Bethesda Conference:    matching the intensity of risk factor management with the hazard for coronary    disease events. Task Force 5. Stratification of patients into high, medium and    low risk subgroups for purposes of risk factor management. J Am Coll Cardiol.    1996; 27 (5): 1007-19.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>1007</fpage>
          <lpage>19</lpage>
          <issue>5</issue>
          <volume>27</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Califf</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Armstrong</surname>
              <given-names>PW</given-names>
            </name>
            <name>
              <surname>Carver</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>D'Agostino</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Strauss</surname>
              <given-names>WE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B36">
        <mixed-citation>36. Emond M, Mock    MB, Davis KB, Fisher LD, Holmes DR, Chaitman BR, et al. Long-term survival of    medically treated patients in the Coronary Artery Surgery Study (CASS) Registry.    Circulation. 1994; 90 (6): 2645-57.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry</article-title>
          <source>Circulation</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>2645</fpage>
          <lpage>57</lpage>
          <issue>6</issue>
          <volume>90</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Emond</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mock</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>KB</given-names>
            </name>
            <name>
              <surname>Fisher</surname>
              <given-names>LD</given-names>
            </name>
            <name>
              <surname>Holmes</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Chaitman</surname>
              <given-names>BR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B37">
        <mixed-citation>37. Kobayashi Y,    Mehran R, Mintz GS, Dangas G, Moussa I, Lansky AJ, et al. Comparison of in-hospital    and one-year outcomes after multiple coronary arterial stenting in patients    &gt; or = 80 years old versus those &lt; 80 years old. Am J Cardiol. 2003; 92    (4): 443-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Comparison of in-hospital and one-year outcomes after multiple coronary arterial stenting in patients &gt; or = 80 years old versus those &lt; 80 years old</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>443</fpage>
          <lpage>6</lpage>
          <issue>4</issue>
          <volume>92</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kobayashi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Mehran</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mintz</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Dangas</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Moussa</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Lansky</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B38">
        <mixed-citation>38. Cohen HA, Williams    DO, Holmes DR Jr, Selzer F, Kip KE, Johnston JM, et al. Impact of age on procedural    and 1-year outcome in percutaneous transluminal coronary angioplasty: a report    from the NHLBI Dynamic Registry. Am Heart J. 2003; 146 (3): 513-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Impact of age on procedural and 1-year outcome in percutaneous transluminal coronary angioplasty: a report from the NHLBI Dynamic Registry</article-title>
          <source>Am Heart J</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>513</fpage>
          <lpage>9</lpage>
          <issue>3</issue>
          <volume>146</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cohen</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>DO</given-names>
            </name>
            <name>
              <surname>Holmes DR</surname>
              <given-names>Jr</given-names>
            </name>
            <name>
              <surname>Selzer</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kip</surname>
              <given-names>KE</given-names>
            </name>
            <name>
              <surname>Johnston</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Clinical and angiographic profile in coronary artery disease: hospital outcome with emphasis on the very elderly</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: Knowing the risk factors and clinical manifestations of coronary artery disease (CAD) allows us to intervene more effectively with a particular population. OBJECTIVE: To identify clinical and angiographic profiles of patients undergoing cardiac catheterization, treated at a tertiary hospital and treated by percutaneous coronary interventions (PCI). METHODS: The study of 1,282 patients who underwent 1,410 cardiac catheterizations, selected from March/2007 to May/2008 from a database in a general hospital for diagnosis of coronary artery disease (CAD). Risk factors, indication for examination, technical details of PCI and in-hospital outcomes were prospectively collected. RESULTS: There were 688 (54.0%) males, mean age 65.4 &#177; 10.9 years and 20.0% above 75 years age. The most frequent clinical condition was acute coronary syndrome (ACS) without ST-segment elevation (STS) (38.7%). The multi artery CAD occurred in 46.4%, PCI was indicated in 464 patients, 547 target lesions were treated (type B2 or C, 86.0%), and of these, 14.0% treated with drug eluting stents. Among those with AMI with STS, primary PCI was performed in 19.0% of the patients, from these, 77.0% were transferred from the origin hospitals late (late PCI) and had not received prior thrombolytic, and 4.0% had PCI rescue. Angiographic success was achieved in 94.2% of PCIs. Death occurred in 5.6% of patients, with average age of 75.2 &#177; 10.2 years. CONCLUSION: The prevalence of elderly (20.1% being &gt; 75 years) and male was observed. From the risk factors for CAD, the most common were systemic hypertension and dyslipidemia. There was a predominance of ACS. Age &gt; 75 years old, multiarterial CAD and chronic renal failure were predictors of in-hospital deaths.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Coronary artery disease</kwd>
        <kwd>aged</kwd>
        <kwd>heart catheterization</kwd>
        <kwd>sickness impact profile</kwd>
        <kwd>risk factors</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ORIGINAL ARTICLE</bold>
      </p>
      <p>
        <fn id="top-body2">
          <label>
            <bold>Clinical and angiographic profile in coronary artery disease: hospital outcome with emphasis on the very elderly</bold>
          </label>
          <p>
            <bold>Micheli Zanotti Galon<sup>I</sup>; George C&#233;sar Ximenes Meireles<sup>I</sup>; S&#233;rgio Kreimer<sup>I</sup>; Gilberto Guilherme Ajjar Marchiori<sup>I</sup>; Desid&#233;rio Favarato<sup>II</sup>; Jo&#227;o Aparecido Pimenta de Almeida<sup>I</sup>; Lorena Squassante Capeline<sup>I</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Hospital do Servidor P&#250;blico Estadual, S&#227;o Paulo, SP - Brazil</p>
      <p><sup>II</sup>Instituto do Cora&#231;&#227;o - HC/FMUSP, S&#227;o Paulo, SP - Brazil</p>
      <p>Mailing address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p><bold>BACKGROUND:</bold> Knowing the risk factors and clinical manifestations of coronary artery disease (CAD) allows us to intervene more effectively with a particular population.</p>
      <p><bold>OBJECTIVE:</bold> To identify clinical and angiographic profiles of patients undergoing cardiac catheterization, treated at a tertiary hospital and treated by percutaneous coronary interventions (PCI).</p>
      <p><bold>METHODS:</bold> The study of 1,282 patients who underwent 1,410 cardiac catheterizations, selected from March/2007 to May/2008 from a database in a general hospital for diagnosis of coronary artery disease (CAD). Risk factors, indication for examination, technical details of PCI and in-hospital outcomes were prospectively collected.</p>
      <p><bold>RESULTS:</bold> There were 688 (54.0%) males, mean age 65.4 &#177; 10.9 years and 20.0% above 75 years age. The most frequent clinical condition was acute coronary syndrome (ACS) without ST-segment elevation (STS) (38.7%). The multi artery CAD occurred in 46.4%, PCI was indicated in 464 patients, 547 target lesions were treated (type B2 or C, 86.0%), and of these, 14.0% treated with drug eluting stents. Among those with AMI with STS, primary PCI was performed in 19.0% of the patients, from these, 77.0% were transferred from the origin hospitals late (late PCI) and had not received prior thrombolytic, and 4.0% had PCI rescue. Angiographic success was achieved in 94.2% of PCIs. Death occurred in 5.6% of patients, with average age of 75.2 &#177; 10.2 years.</p>
      <p><bold>CONCLUSION:</bold> The prevalence of elderly (20.1% being <underline>&gt;</underline> 75 years) and male was observed. From the risk factors for CAD, the most common were systemic hypertension and dyslipidemia. There was a predominance of ACS. Age <underline>&gt;</underline> 75 years old, multiarterial CAD and chronic renal failure were predictors of in-hospital deaths.</p>
      <p><bold>Key words:</bold> Coronary artery disease; aged; heart catheterization; sickness impact profile; risk factors.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>The prevalence of coronary artery disease (CAD) has been progressively increasing worldwide as a result of increased life expectancy and survival to acute conditions. Facts that are also seen in Brazil<sup>1</sup>.</p>
      <p>Cardiovascular diseases have significant morbidity and mortality in the elderly. The World Health Organization (WHO) considers elderly in developing countries, those who are 60 years old or older and in developed countries, individuals aged 65 years old or older. In the U.S., the elderly constitute 13.0% of the population, which accounts for 65.0% of hospitalizations for heart disease. About 85.0% of deaths from AMI occur in the elderly population<sup>2,3</sup>.</p>
      <p>In elderly patients, percutaneous coronary intervention (PCI) is a strategy of revascularization often used<sup>4,5</sup>. Observational data of the 90's suggested that elderly patients are a high-risk group for PCI<sup>6,7</sup>; progressing to higher mortality rates when compared to younger individuals.</p>
      <p>Elderly patients with acute coronary syndrome (ACS) often have different risk profile from non elderly: they have a higher prevalence of arterial hypertension, diabetes mellitus, myocardial infarctation, angina, peripheral vascular disease, cerebral vascular accident (CVA), multi artery disease and heart failure. On the other hand, they have lower cholesterol levels and a lower prevalence of smoking. Generally, the elderly search for medical care later, after the onset of symptoms. In the event of ACS, instead of pain, they frequently have the so-called "ischemic equivalents," such as dyspnea, malaise, confusion, syncope or pulmonary edema. Also in relation to non elderly, the elderly have lower elevation of cardiac enzymes and a higher incidence of ACS without STS<sup>8</sup>. In the patients over 75 years old, the best therapy with betablocker, ASA, anticoagulant and hypolipemiant is the least used, as well as fibrinolytic and revascularization by angioplasty or surgery<sup>9,10</sup>.</p>
      <p>The aim of this study was to evaluate patients with suspected CAD who underwent cardiac catheterization and PCI with special focus on the population aged 75 years old or more, their baseline clinical characteristics at admission, medical treatment and outcome in hospital.</p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>
        <bold>Sample selection</bold>
      </p>
      <p>Hospital do Servidor P&#250;blico serves patients from a service network covering the city of S&#227;o Paulo and 18 Medical Centers of Ambulatory Care (CEAMAS), located in the inner cities of S&#227;o Paulo state. Currently, <italic>Instituto de Assist&#234;ncia M&#233;dica ao Servidor P&#250;blico Estadual</italic> (IAMSPE) includes 1,239,287 aggregated people, involving contributors and beneficiaries, and HSPE is reference to highly complex procedures such as cardiac catheterization. Patients over 70 years old were responsible for about 30.0% of admissions in the last seven years. 1,410 cardiac catheterizations were performed in 1,282 patients for clarifying diagnosis of CAD and included consecutively in a database prospectively from March/2007-May/2008, by completing a clinical record used to record information about the baseline clinical characteristics, symptoms at admission, electrocardiographic changes, laboratory tests, medical treatment and in-hospital evolution of patients. To avoid selection bias, exclusion criteria were not applied and all patients who underwent cardiac catheterization for clarification of CAD in this period were included. The study was approved by the Ethics Committee in Research of the Office of Medical Assistance for Public Servants of the State in accordance with the Declaration of Helsinki.</p>
      <p>
        <bold>Analyzed characteristics</bold>
      </p>
      <p>As per clinical presentation modalities of CAD, patients were characterized as stable angina (SA), ACS without ST-segment elevation (STS), ACS with STS or ischemic equivalent (atypical manifestations of ACS as dyspnea, malaise, confusion, syncope or pulmonary edema). Risk factors for CAD and its comorbidities were documented at the time of catheterization, by completing a questionnaire: diabetes mellitus (if present, the therapeutic regimen in use is specified: Insulin, oral hypoglycemic agents, diet), smoking, history of CAD in the family, cerebrovascular accident (CVA) /transient ischemic attack (TIA), chronic kidney failure (if present, treatment regimen of dialysis or conservative treatment), dyslipidemia, coronary history (if prior AMI, myocardium revascularization or PCI).</p>
      <p>The angiographic characteristics such as extent of CAD (characterized by the number of vessels with angiographic lesion over 50.0% - one, two or three-arteries), TIMI flow before PCI (TIMI 0/1, or when there is absence or discrete flow distal to target lesion; TIMI 2, when there is flow distal to target lesion of the entire coronary, delayed, though; TIMI 3, when there is flow distal to target lesion of the entire coronary compatible with normality) and the treated vessel (if native coronary, venous/arterial or vessel graft with restenosis) were documented and analyzed.</p>
      <p>
        <bold>Cardiac catheterization and percutaneous coronary intervention</bold>
      </p>
      <p>PCIs were performed according to standard methods and guidelines orientations in force<sup>11-13</sup>.</p>
      <p>Angiographic and procedure success<sup>11</sup> was defined as: 1) angiographic: reduction of target stenosis to a stenosis diameter of &lt; 30.0%, with maintenance or restoration of TIMI 3 flow, as assessed by quantitative coronary angiography; 2) procedure: achievement of angiographic success and absence of major clinical complications (death, AMI with STS and emergency myocardial revascularization surgery). The definition of AMI after a procedure takes into account the development of new Q waves and/or elevation of CK-MB (&gt; three times its baseline), with or without associated precordialgia.</p>
      <p>The coronary lesions were divided into A, B1, B2 and C<sup>11</sup>; according to the classification of the American College of Cardiology and American Heart Association. The characteristics of high risk (type C) were: lesion length &gt; 20 mm, massive calcification, excessive tortuosity of proximal segment, target segment with extreme angulation (&gt; 90 degrees), chronic occlusion in blunt tip, inability to protect significant lateral (<underline>&gt;</underline> 2.5 mm) and stenotic (&gt; 50%) branch, degenerated vein grafts.</p>
      <p>
        <bold>In-hospital outcomes</bold>
      </p>
      <p>Patients were followed up during hospitalization, with the intent to highlight complications associated with both diagnostic and therapeutic procedures, the latter being more frequent. The complications were categorized as major were death, myocardial infarctation, emergency MR and CVA (loss of neurological function of vascular cause that lasts longer than 24 hours). Minor complications were: access site complications, renal failure secondary to contrast-induced nephropathy (relative increase of 25 to 50.0% or absolute of 0.5 mg/dl of baseline creatinine after contrast exposure), adverse reactions to radiological contrast, TIA (focal neurological deficit of sudden onset lasting less than 24 hours, presumably of vascular origin and confined to one area of the brain, or eye, irrigated by a specific artery)<sup>14</sup>.</p>
      <p>The medications used during hospitalization were prescribed by the physician in charge, being documented by completing the medical record, emphasizing: fractionated and low molecular weight heparin, tirofiban, ASA, clopidogrel, ticlopidine, nitrate, betablockers, calcium channel blocker, angiotensin converting enzyme inhibitor, nitrate, insulin, oral hypoglycemic agents<sup>15</sup>.</p>
      <p>
        <bold>2.5. Statistical analysis</bold>
      </p>
      <p>A total of 1,282 patients who underwent 1,410 cardiac catheterizations were evaluated for diagnosis clarification of CAD, and therapeutic clarification for treatment of coronary stenosis, according to inclusion and exclusion criteria.</p>
      <p>Quantitative variables were presented as means and standard deviations and the absolute and relative frequencies for qualitative variables were calculated.</p>
      <p>To compare the associations between clinical and angiographic variables and the occurrence of death, chi-square test or Fisher's exact test were used. The ages were divided into three age groups (&lt; 60 years old, 60-74 years old and <underline>&gt;</underline> 75 years old).</p>
      <p>To compare the distributions of creatinine clearance among patients younger than 75 years old or 75 years old or more nonparametric ANOVA Kruskal-Wallis was used.</p>
      <p>To study the clinical and angiographic correlations and death, in a multivariate way, logistic regression model with stepwise variable selection process was used.</p>
      <p>The significance level used was 5.0%.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>
        <bold>Overview of the study population</bold>
      </p>
      <p>In the study period, 1,410 cardiac catheterizations were performed in 1,282 patients for CAD diagnostic clarification. <xref ref-type="table" rid="t1-body2">Table 1</xref> outlines the main baseline clinical characteristics of this population. 688 (54.0%) males, mean age of 65.4 years old (&#177; 10.9) and 20.1% above 75 years old. Among the classic risk factors for CAD, the most common were systemic arterial hypertension and dyslipidemia. Diabetes mellitus was present in 31.6% of patients.</p>
      <table-wrap id="t1-body2">
        <graphic xlink:href="1678-4170-abc-95-04-0422-00127-gt01-en.jpg"/></table-wrap>
      <p>The confirmed clinic condition that triggered the most catheterization was ACS without STS (38.7%). Among AMI with STS, primary PCI was performed in only 19.0%; 77.0% were transferred from origin hospitals late (late PCI) and had not received prior thrombolytic, 4.0% underwent rescue PCI (<xref ref-type="fig" rid="en_aop12310c01-body2">Chart 1</xref>). Among patients who were not referred for primary PCI, only 12.0% of patients received thrombolytic treatment.</p>
      <p content-type="asset">
        <fig id="en_aop12310c01-body2">
          <graphic xlink:href="1678-4170-abc-95-04-0422-00127-gf01-en.jpg"/></fig>
      </p>
      <p>Multiartery coronary artery disease occurred in 46.4% of coronariographies, PCI was indicated in 464 patients and 547 treated target lesions (type B2 or C in 86.6%), located mostly in native vessels (94.7%) and treated with stents, 14.6% with drug-eluting stent (<xref ref-type="table" rid="t2-body2">Table 2</xref>).</p>
      <table-wrap id="t2-body2">
        <graphic xlink:href="1678-4170-abc-95-04-0422-00127-gt02-en.jpg"/></table-wrap>
      <p>Procedural success was achieved in 94.2% of PCIs. When analyzed by clinical situation, ACS patients without STS and those with STS undergoing angioplasty within the first 12 hours were successful in 97.1%, while patients with ACS with STS treated late (&gt; 24 hours) and who kept clinical evidence of ischemia, such as post-infarctation angina, acute pulmonary edema attributed to ischemia, among other presentations considered by the clinician of the patient as a result of ischemia, were successful in 90.4%. Among patients with stable angina and atypical manifestations of CAD, the procedural success was achieved in 97.2% and 100.0% respectively.</p>
      <p>AMI after PCI was observed in 2.8% of patients, among these, one patient with acute thrombosis (first 24 hours after PCI) of eluting stents (Supralimus 2.5 x 39 mm), possibly due to the stent hypoexpansion in a portion of the lesion with severe calcification of the artery. There was no need for emergency MR (<xref ref-type="table" rid="t3-body2">Table 3</xref>).</p>
      <table-wrap id="t3-body2">
        <graphic xlink:href="1678-4170-abc-95-04-0422-00127-gt03-en.jpg"/></table-wrap>
      <p>Among patients undergoing coronary angiography, renal failure secondary to contrast-induced nephropathy occurred in 20 patients (1.6%), of which one quarter required dialysis as therapy. Bleeding from the arterial access way occurred in one patient (femoral), requiring blood transfusion. It was not observed pseudoaneurysm at the puncture site and was not observed inferior or superior limb ischemia (in the case of the radial procedure), ischemic or hemorrhagic CVA.</p>
      <p>Death after PCI occurred in 5.2%, mean age of 75.2 &#177; 10.2 years old. The number of vessels affected by severe lesions was associated with in-hospital mortality: one, two, three vessels or left trunk coronary had a mortality rate of 0.54%, 3.33% and 3.41% respectively (p = 0.0005).</p>
      <p>The most used drugs by the patients at the time of catheterization (<xref ref-type="table" rid="t4-body2">Table 4</xref>) were ASA (65.7%) and statin (52.3%). Overall, patients undergoing PCI received dual antiplatelet therapy (ASA and clopidogrel) after the angioplasty (97.3%).</p>
      <table-wrap id="t4-body2">
        <graphic xlink:href="1678-4170-abc-95-04-0422-00127-gt04-en.jpg"/></table-wrap>
      <p>Hospital stay was longer in patients with clinical symptoms of ACS (13.7 days).</p>
      <p>
        <bold>Comparative analysis between patients younger than 75 years old and older than or equal to 75 years old</bold>
      </p>
      <p>Patients who are 75 years old or older had creatinine clearance (CrCL) lower than the patients younger than 75 years old (42.06 and 68.18 l/min/1.73m<sup>2</sup>; respectively, p &lt; 0.00001). In comparison with males, the female patients undergoing cardiac catheterization were older.</p>
      <p>Mortality among those over 75 years old was higher than in those under 75 years old (5.0% <italic>versus</italic> 1%, p = 0.000097), as in previous CRF (5.3% <italic>versus</italic> 1.3%, p = 0.0028), as seen in <xref ref-type="table" rid="t5-body2">Table 5</xref>. All deaths were in patients with ACS (with ST = 37.5%; without ST elevation = 62.5%).</p>
      <table-wrap id="t5-body2">
        <graphic xlink:href="1678-4170-abc-95-04-0422-00127-gt05-en.jpg"/></table-wrap>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>The present study is the first report on clinical and angiographic characteristics of the population of servers in the state of S&#227;o Paulo who underwent cardiac catheterization for clarifying diagnosis of coronary artery disease and therapeutic treatment of coronary stenoses in the <italic>Servi&#231;o de Hemodin&#226;mica e Cardiologia do Servidor P&#250;blico Estadual (HSPE) - Francisco Morato de Oliveira (FMO), IAMSPE</italic>.</p>
      <p>The population served in HSPE-FMO, IAMSPE is characterized by the prevalence of elderly patients and patients over 70 years old account for approximately 30.0% of the admissions information of great importance since such patients are often excluded from clinical trials<sup>34</sup>. It can also evaluate the use and adherence to the medical therapeutic procedures<sup>34, 35</sup>. With this record, we describe a specific population, presenting your profile and how it has led to the diagnosis of CAD research and treatment of this clinical entity in light of the recommended guidelines and numerous clinical trials.</p>
      <p>According to data from <italic>Funda&#231;&#227;o Seade</italic>, the number of elderly people in S&#227;o Paulo state is 4.3 million and from this total, 1.9 million is composed of persons aged 70 or older (www.seade.org.br ). In 2020, there will be 7.1 million elderly people in S&#227;o Paulo state, from this total, consisting of 2.9 million people aged 70 or more. Hence, the great importance of epidemiological studies showing prevalence of elderly population.</p>
      <p>One of the most important observations was the large number of patients with ACS without ST elevation (38.7%) in a general hospital, a figure comparable to the 40.0% of emergency centers in cardiology<sup>16</sup>. The coronary angiography allows the precise identification of the extent and severity of coronary obstructions, complements the prognostic stratification and the identification of the most appropriate treatment (medical, surgical or percutaneous revascularization), regarding the coronary anatomy presented angiographically.</p>
      <p>Two strategies emerge for the treatment of these patients: an early invasive strategy, coronariography within 72 hours, and conservative strategy, after 72 hours of hospital admission<sup>17,18</sup>. Although there is not unanimity on the best strategy, the most recent evidence supports an early invasive strategy. All these trials support the prescription of the "invasive strategy" because it reduced the mortality and the occurrence of late infarctation such as re-hospitalization due to ACS<sup>18-21</sup>.</p>
      <p>On this record, we applied the early invasive strategy to identify patients at highest risk, as patients with severe multi artery CAD (23.0%) and stenoses in left coronary trunk (2.0%). Despite this conduct, we observed a delay in the indication for catheterization, and the patient was referred to the hemodynamics frequently only when admitted to the coronary care unit or cardiology ward, after evaluation by a cardiologist. Such conduct is possibly reflected in a longer period of hospitalization.</p>
      <p>In patients with ACS with STS, the elapsed time between the onset of pain and coronary recanalization, chemical or mechanical, is the fundamental factor for the benefit of treatment, both immediate and late, considering the relationship with mortality and morbidity in patients treated within 12 hours of onset of pain. Concerning, in relation to patients with such diagnosis transferred from other hospitals, is the fact that they do not receive appropriate reperfusion therapy, either by delay in transferring or no previous administration of thrombolytic therapy (only 19.0% of primary PCI in the first 12 hours and 12.0% of thrombolytic therapy in this record). This fact affected the success rate of the procedure as described in the results, since patients undergoing PCI within the first 12 hours were successful in 97.1% and those who underwent late PCI, 90.4% (PCI was performed, as, according to the clinical condition of patients, there was clinical myocardial ischemia evidence).</p>
      <p>Studies have shown that PCI elective prescription for an occluded coronary artery within one to 28 days after the AMI occurrence in stable patients, did not provide any benefit greater than that offered by medical therapy consisting of aspirin, betablockers, angiotensin converting enzyme inhibitors and statins in preserving left ventricular contractile function and new cardiovascular events<sup>22,23</sup>.</p>
      <p>Literature data have shown the benefits of primary PCI, compared to fibrinolysis. Primary PCI is capable of restoring normal epicardial coronary flow (TIMI grade 3) in more than 90.0% of patients, which is associated with reduced rates of recurrent ischemia and re infarctation, without the risk of severe bleeding complications, such as CBA<sup>24-26</sup>.</p>
      <p>Groups of patients considered as high risk, such as the elderly, often have an indication of coronary angiography delayed or prevented, in evident contradiction to literature<sup>27,28</sup>. This strategy deprives these patients of the possibility of treatment, as they would have greater benefit in early revascularization, reflected in mortality and/or re infarctation rates. This behavior seems to occur in this record, considering the average age of 65.4 years old (&#177; 10.9) of patients undergoing catheterization, being 20.1% aged 75 years or more.</p>
      <p>In CSA, the elderly have a higher incidence of complications, which implies the need for more intensive treatment. However, especially for those above 75 years old, often the best therapy, with beta-blockers, ASA, anticoagulant and hypolipemiant is not used<sup>9,29</sup>. During in-hospital period, this difference in drug prescription was not observed in this record.</p>
      <p>Our study found that among patients undergoing PCI, those aged 75 years old or more had a higher mortality, although the angiographic success was similar for persons under 75 years old. Complications remain more common in older patients, the prevalence of post-procedure renal failure due to contrast-induced nephropathy was consistent with the literature. Mehran et al<sup>30</sup> assessed the risk factors for contrast-induced nephropathy, determining a score for stratification of risk for the development of acute renal failure after PCI. Whereas the elderly population has reduced glomerular filtration rate, it is presumed that the contrast-induced nephropathy would occur more often in this group of individuals. Although this event can be anticipated, the related morbidity is still significant, making this risk considered in indicating the procedure. In cases of patients with high probability for contrast-induced nephropathy, prophylactic measures such as hydration, use of low molecular weight contrast and alternative measures, such as hydration and bicarbonate<sup>31</sup> and acetylcysteine<sup>32</sup>; should be considered.</p>
      <p>The increased risk of developing acute renal failure has also been reported in patients with chronic renal failure with ACS with STS undergoing early PCI<sup>33,34</sup>. In this group of patients, prophylaxis of acute renal failure can be done, and usually it is possible to obtain clinical stability of patients before intervention, unlike patients with ACS with STS who underwent primary PCI, when prior hydration is not possible and the hemodynamic instability is more common. Our record has identified that patients with chronic renal failure had higher in-hospital mortality, despite renal preparation accomplish and avoidance of the early invasive strategy in these patients.</p>
      <p>Elderly patients are more often multiarterial disease. The survival time decreases with the involvement of additional vessels, with the involvement of the anterior descending and left ventricular dysfunction<sup>35,36</sup>.</p>
      <p>Our analysis shows that both younger and elderly patients can benefit from the PCI, with high rates of success, a fact that has also been observed by other authors<sup>37,38</sup>. Age can not be considered a limiting factor for percutaneous procedures.</p>
      <p>
        <bold>Conclusion</bold>
      </p>
      <p>In this population, there is a predominance of elderly, 20.1% above 75 years old and male. Among the risk factors for CAD, the most common ones were systemic arterial hypertension and dyslipidemia. There was a predominance of acute coronary syndrome. Age greater than or equal to 75 years old, multiarterial CAD and chronic renal failure were predictors of in-hospital deaths in patients undergoing PCI.</p>
      <p>Patients aged 75 years or more showed clinical/angiographic high-risk and rate of procedural success similar to younger patients, showing that the PCI is a technique safe and effective in this group of patients.</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>There were no external funding sources for this study.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the thesis of master submitted by Micheli Zanotti Galon, from <italic>Instituto de Assist&#234;ncia M&#233;dica ao Servidor P&#250;blico Estadual</italic>.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Art&#237;culos Originales</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="es">Perfil cl&#237;nico-angiogr&#225;fico en la enfermedad arterial coronaria: desenlace hospitalario con &#233;nfasis en los muy a&#241;osos</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>FUNDAMENTO: Conocer factores de riesgo y manifestaciones cl&#237;nicas de la enfermedad arterial coronaria (EAC) nos permite intervenir de manera m&#225;s eficaz en una determinada poblaci&#243;n. OBJETIVO: Identificar perfiles cl&#237;nicos y angiogr&#225;ficos de los pacientes sometidos a cateterismo card&#237;aco, atendidos en un hospital terciario y tratados por medio de intervenciones coronarias percut&#225;neas (ICP). M&#201;TODOS: Casu&#237;stica de 1.282 pacientes sometidos a 1.410 cateterismos card&#237;acos, seleccionados de mar/2007-may/2008 en un banco de datos de un hospital general para diagn&#243;stico de enfermedad arterial coronaria (EAC). Factores de riesgo, indicaci&#243;n del examen, detalles t&#233;cnicos de la ICP y desenlaces intrahospitalarios fueron prospectivamente colectados. RESULTADOS: Fueron 688 (54,0%) pacientes del sexo masculino, con media de edad de 65,4 &#177; 10,9 a&#241;os, siendo 20,0% encima de los 75 a&#241;os. El cuadro cl&#237;nico confirmado con m&#225;s frecuencia fue el de s&#237;ndrome coronario agudo (SCA) sin supradesnivel del segmento ST (SST) (38,7%). La EAC multiarterial ocurri&#243; en 46,4%, fue indicada ICP en 464 pacientes, siendo tratadas 547 lesiones-blanco (tipo B2 o C, en 86,0%), siendo de &#233;stas, 14,0% tratadas con stent farmacol&#243;gico. Entre los IAM con SST, ICP primaria fue realizada en 19,0% de los pacientes, siendo que, de &#233;stos, 77,0% fueron transferidos de los hospitales de origen tard&#237;amente (ICP tard&#237;a) y no recibieron trombol&#237;tico previo, y 4,0% realizaron ICP de rescate. Fue obtenido &#233;xito angiogr&#225;fico en 94,2% de las ICPs. Sucedi&#243; &#243;bito en 5,6% de los pacientes, teniendo &#233;stos una media de edad de 75,2 &#177; 10,2 a&#241;os. CONCLUSI&#211;N: Observamos predominio de a&#241;osos (siendo 20,1% &gt; 75 a&#241;os) y del sexo masculino. De los factores de riesgo para EAC, los m&#225;s frecuentes fueron hipertensi&#243;n arterial sist&#233;mica y dislipidemia. Ocurri&#243; predominio de la SCA. La edad &gt; 75 a&#241;os, EAC multiarterial y la insuficiencia renal cr&#243;nica fueron los predictores de &#243;bito intrahospitalario.</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>Enfermedad de la arteria coronaria</kwd>
        <kwd>a&#241;oso</kwd>
        <kwd>cateterismo card&#237;aco</kwd>
        <kwd>perfil de impacto de la enfermedad</kwd>
        <kwd>factores de riesgo</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ART&#205;CULO ORIGINAL</bold>
      </p>
      <p>
        <fn id="top-body3">
          <label>
            <bold>Perfil cl&#237;nico-angiogr&#225;fico en la enfermedad arterial coronaria: desenlace hospitalario con &#233;nfasis en los muy a&#241;osos</bold>
          </label>
          <p>
            <bold>Micheli Zanotti Galon<sup>I</sup>; George C&#233;sar Ximenes Meireles<sup>I</sup>; S&#233;rgio Kreimer<sup>I</sup>; Gilberto Guilherme Ajjar Marchiori<sup>I</sup>; Desid&#233;rio Favarato<sup>II</sup>; Jo&#227;o Aparecido Pimenta de Almeida<sup>I</sup>; Lorena Squassante Capeline<sup>I</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Hospital do Servidor P&#250;blico Estadual, S&#227;o Paulo, SP - Brasil</p>
      <p><sup>II</sup>Instituto do Cora&#231;&#227;o - HC/FMUSP, S&#227;o Paulo, SP - Brasil</p>
      <p>Correspondencia</p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p><bold>FUNDAMENTO:</bold> Conocer factores de riesgo y manifestaciones cl&#237;nicas de la enfermedad arterial coronaria (EAC) nos permite intervenir de manera m&#225;s eficaz en una determinada poblaci&#243;n.</p>
      <p><bold>OBJETIVO:</bold> Identificar perfiles cl&#237;nicos y angiogr&#225;ficos de los pacientes sometidos a cateterismo card&#237;aco, atendidos en un hospital terciario y tratados por medio de intervenciones coronarias percut&#225;neas (ICP).</p>
      <p><bold>M&#201;TODOS:</bold> Casu&#237;stica de 1.282 pacientes sometidos a 1.410 cateterismos card&#237;acos, seleccionados de mar/2007-may/2008 en un banco de datos de un hospital general para diagn&#243;stico de enfermedad arterial coronaria (EAC). Factores de riesgo, indicaci&#243;n del examen, detalles t&#233;cnicos de la ICP y desenlaces intrahospitalarios fueron prospectivamente colectados.</p>
      <p><bold>RESULTADOS:</bold> Fueron 688 (54,0%) pacientes del sexo masculino, con media de edad de 65,4 &#177; 10,9 a&#241;os, siendo 20,0% encima de los 75 a&#241;os. El cuadro cl&#237;nico confirmado con m&#225;s frecuencia fue el de s&#237;ndrome coronario agudo (SCA) sin supradesnivel del segmento ST (SST) (38,7%). La EAC multiarterial ocurri&#243; en 46,4%, fue indicada ICP en 464 pacientes, siendo tratadas 547 lesiones-blanco (tipo B2 o C, en 86,0%), siendo de &#233;stas, 14,0% tratadas con stent farmacol&#243;gico. Entre los IAM con SST, ICP primaria fue realizada en 19,0% de los pacientes, siendo que, de &#233;stos, 77,0% fueron transferidos de los hospitales de origen tard&#237;amente (ICP tard&#237;a) y no recibieron trombol&#237;tico previo, y 4,0% realizaron ICP de rescate. Fue obtenido &#233;xito angiogr&#225;fico en 94,2% de las ICPs. Sucedi&#243; &#243;bito en 5,6% de los pacientes, teniendo &#233;stos una media de edad de 75,2 &#177; 10,2 a&#241;os.</p>
      <p><bold>CONCLUSI&#211;N:</bold> Observamos predominio de a&#241;osos (siendo 20,1% <underline>&gt;</underline> 75 a&#241;os) y del sexo masculino. De los factores de riesgo para EAC, los m&#225;s frecuentes fueron hipertensi&#243;n arterial sist&#233;mica y dislipidemia. Ocurri&#243; predominio de la SCA. La edad <underline>&gt;</underline> 75 a&#241;os, EAC multiarterial y la insuficiencia renal cr&#243;nica fueron los predictores de &#243;bito intrahospitalario.</p>
      <p><bold>Palabras clave:</bold> Enfermedad de la arteria coronaria, a&#241;oso, cateterismo card&#237;aco, perfil de impacto de la enfermedad, factores de riesgo.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>La prevalencia de enfermedad arterial coronaria (EAC) viene aumentando progresivamente en todo el mundo, a consecuencia del aumento de la expectativa de vida y de la supervivencia a los cuadros agudos. Hechos que tambi&#233;n son verificados en el Brasil<sup>1</sup>.</p>
      <p>Las enfermedades cardiovasculares presentan significativa morbimortalidad en la poblaci&#243;n a&#241;osa. La Organizaci&#243;n Mundial de la Salud (OMS) considera a&#241;osos, en los pa&#237;ses en desarrollo, los individuos con 60 o m&#225;s a&#241;os y, en los pa&#237;ses desarrollados, los individuos con 65 o m&#225;s a&#241;os. En los Estados Unidos, los a&#241;osos constituyen 13,0% de la poblaci&#243;n, que responden por 65,0% de las hospitalizaciones por enfermedad card&#237;aca. Cerca de 85,0% de las muertes por IAM ocurren en la poblaci&#243;n a&#241;osa<sup>2,3</sup>.</p>
      <p>En pacientes a&#241;osos, la intervenci&#243;n coronaria percut&#225;nea (ICP) es una estrategia de revascularizaci&#243;n mioc&#225;rdica frecuentemente utilizada<sup>4,5</sup>. Datos observacionales de la d&#233;cada de 90 sugieren que los pacientes a&#241;osos son un grupo de riesgo elevado para ICP<sup>6,7</sup>, evolucionando con mayor mortalidad cuando son comparados a los individuos m&#225;s j&#243;venes.</p>
      <p>Los a&#241;osos con s&#237;ndrome coronario agudo (SCA) generalmente presentan perfil de riesgo diferente de los no a&#241;osos: tienen mayor prevalencia de hipertensi&#243;n arterial, diabetes mellitus, infarto de miocardio previo, angina, enfermedad vascular perif&#233;rica, accidente vascular encef&#225;lico (AVE), enfermedad multiarterial e insuficiencia card&#237;aca. Por otro lado, presentan niveles menos elevados de colesterol y menor prevalencia de tabaquismo. Generalmente, el a&#241;oso se presenta a la atenci&#243;n m&#233;dica m&#225;s tard&#237;amente, despu&#233;s del comienzo de los s&#237;ntomas. En el caso de las SCA, en vez de dolor, frecuentemente presentan los llamados "equivalentes isqu&#233;micos", como disnea, malestar, confusi&#243;n mental, s&#237;ncope o edema pulmonar. Aun en relaci&#243;n a los no a&#241;osos, los a&#241;osos tienen menor elevaci&#243;n de las enzimas card&#237;acas y mayor ocurrencia de SCA sin SST<sup>8</sup>. En los pacientes encima de 75 a&#241;os, la terap&#233;utica m&#225;s adecuada, con betabloqueante, AAS, anticoagulante y hipolipemiante, es la menos utilizada, as&#237; como fibrinol&#237;ticos y la revascularizaci&#243;n por angioplastia o por cirug&#237;a<sup>9,10</sup>.</p>
      <p>El objetivo del presente estudio fue evaluar los pacientes con sospecha de EAC, sometidos a cateterismo card&#237;aco e ICP con enfoque especial en la poblaci&#243;n con 75 a&#241;os o m&#225;s, sus caracter&#237;sticas cl&#237;nicas basales, modalidades de presentaci&#243;n, tratamiento m&#233;dico y desenlaces intrahospitalarios.</p>
      <p>
        <bold>M&#233;todos</bold>
      </p>
      <p>
        <bold>Selecci&#243;n de la muestra</bold>
      </p>
      <p>El Hospital del Servidor P&#250;blico Estadual atiende pacientes de una red de servicios que comprende la ciudad de S&#227;o Paulo y 18 Centros de Asistencia M&#233;dico-Ambulatoria (CEAMAS), ubicados en las ciudades del interior del estado de S&#227;o Paulo. Actualmente, el Instituto de Asistencia M&#233;dica al Servidor P&#250;blico Estadual (IAMSPE) comprende 1.239.287 personas agregadas, englobando contribuyentes y beneficiarios, siendo el HSPE la referencia para procedimientos de alta complejidad, como el cateterismo card&#237;aco. Los pacientes encima de 70 a&#241;os fueron los responsables por cerca de 30,0% de las internaciones en los &#250;ltimos 7 a&#241;os.</p>
      <p>Fueron 1.410 cateterismos card&#237;acos realizados en 1.282 pacientes para esclarecimiento diagn&#243;stico de EAC e incluidos, consecutivamente, en un banco de datos de forma prospectiva de mar/2007-may/2008, por medio del llenado de una ficha cl&#237;nica utilizada para registrar las informaciones sobre las caracter&#237;sticas cl&#237;nicas basales, s&#237;ntomas de presentaci&#243;n, alteraciones electrocardiogr&#225;ficas, ex&#225;menes de laboratorio, tratamiento m&#233;dico y evoluci&#243;n intrahospitalaria de los pacientes. Para evitar el sesgo de selecci&#243;n, criterios de exclusi&#243;n no fueron aplicados y todos los pacientes sometidos a cateterismo card&#237;aco para esclarecimiento de EAC en este per&#237;odo fueron incluidos.</p>
      <p>La investigaci&#243;n fue aprobada por la Comisi&#243;n de &#201;tica en Investigaci&#243;n del Instituto de Asistencia M&#233;dica de los Servidores P&#250;blicos del Estado en concordancia con la Declaraci&#243;n de Helsinki.</p>
      <p>
        <bold>Caracter&#237;sticas analizadas</bold>
      </p>
      <p>Seg&#250;n modalidades de presentaci&#243;n cl&#237;nica de la EAC, los pacientes fueron caracterizados como: angina estable (AE), SCA sin supradesnivel del segmento ST (SST), SCA con SST o equivalente isqu&#233;mico (manifestaciones at&#237;picas de la SCA como disnea, malestar, confusi&#243;n mental, s&#237;ncope o edema pulmonar). Los factores de riesgo para EAC y sus comorbilidades fueron documentadas, en el momento de la realizaci&#243;n del cateterismo, a trav&#233;s del llenado de un cuestionario: diabetes mellitus (si presente, especificado el esquema terap&#233;utico en uso: insulinoterapia, hipoglicemiante oral, dieta); tabaquismo; historia familiar para EAC; accidente vascular encef&#225;lico (AVE)/ataque isqu&#233;mico transitorio (AIT); insuficiencia renal cr&#243;nica (si presente, esquema terap&#233;utico de hemodi&#225;lisis o tratamiento conservador); dislipidemia; antecedentes coronarios (si IAM, revascularizaci&#243;n del miocardio o ICP previos).</p>
      <p>Las caracter&#237;sticas angiogr&#225;ficas, como extensi&#243;n de la EAC (caracterizada por el n&#250;mero de vasos con lesi&#243;n angiogr&#225;fica mayor de 50,0% - uni, bi o triarteriales), flujo TIMI antes de la ICP (TIMI 0/1, cuando hubiere ausencia o discreto flujo distal de la lesi&#243;n-blanco; TIMI 2, cuando hubiere flujo distal de la lesi&#243;n-blanco de cualquier coronaria, aunque lentificado; TIMI 3, cuando hubiere flujo distal de la lesi&#243;n-blanco de cualquier coronaria compatible con la normalidad) y vaso tratado (si coronaria nativa, injerto venoso/arterial o vaso con reestenosis) fueron documentadas y analizadas.</p>
      <p>
        <bold>Cateterismo card&#237;aco y intervenci&#243;n coronaria percut&#225;nea</bold>
      </p>
      <p>Las ICP fueron realizadas de acuerdo con las t&#233;cnicas habituales y seg&#250;n las orientaciones de las directrices vigentes<sup>11-13</sup>.</p>
      <p>El &#233;xito angiogr&#225;fico y del procedimiento<sup>11</sup> fue as&#237; definido: 1) angiogr&#225;fico: reducci&#243;n de la estenosis-blanco para un di&#225;metro de estenosis &lt; 30,0%, con manutenci&#243;n o restablecimiento del flujo TIMI 3, evaluado por la angiografia coronaria cuantitativa; 2) del procedimiento: obtenci&#243;n de &#233;xito angiogr&#225;fico y ausencia de complicaciones cl&#237;nicas mayores (muerte, IAM con SST y cirug&#237;a de revascularizaci&#243;n mioc&#225;rdica de emergencia). La definici&#243;n de IAM despu&#233;s de un procedimiento tiene en consideraci&#243;n el desarrollo de nuevas ondas Q y/o la elevaci&#243;n de la CK-MB (&gt; tres veces su valor basal), con o sin la presencia de precordialgia asociada.</p>
      <p>Las lesiones coronarias fueron diferenciadas en A, B1, B2 y C<sup>11</sup>, seg&#250;n la clasificaci&#243;n del <italic>American College of Cardiology</italic> y <italic>American Heart Association</italic>. Las caracter&#237;sticas de alto riesgo (tipo C) fueron: largo de la lesi&#243;n &gt; 20 mm, calcificaci&#243;n, tortuosidad excesiva del segmento proximal, segmento-blanco con angulaci&#243;n extrema (&gt; 90 grados), oclusi&#243;n cr&#243;nica en punta roma, imposibilidad de protecci&#243;n de rama lateral significativa (<underline>&gt;</underline> 2,5 mm) y esten&#243;tica (&gt; 50%), injertos venosos degenerados.</p>
      <p>
        <bold>Desenlaces intrahospitalarios</bold>
      </p>
      <p>Los pacientes fueron controlados durante la internaci&#243;n hospitalaria, con la intenci&#243;n de evidenciar complicaciones asociadas a los procedimientos tanto diagn&#243;sticos como terap&#233;uticos, siendo en estos m&#225;s frecuentes. Las complicaciones categorizadas como mayores fueron muerte, infarto, RM de urgencia y AVE (p&#233;rdida de funci&#243;n neurol&#243;gica de causa vascular que dura m&#225;s de 24 horas). Las complicaciones menores fueron: complicaciones en el local de acceso, insuficiencia renal secundaria a la nefropat&#237;a inducida por el contraste (aumento relativo de 25-50,0% o absoluto de 0,5 mg/dl de la creatinina basal despu&#233;s de exposici&#243;n al contraste), reacciones adversas al contraste radiol&#243;gico, AIT (d&#233;ficit neurol&#243;gico focal de comienzo s&#250;bito con duraci&#243;n menor que 24 horas, de origen presumiblemente vascular y restringido a un &#225;rea del cerebro, o del ojo, irrigada por una arteria espec&#237;fica)<sup>14</sup>.</p>
      <p>Las medicaciones utilizadas durante la internaci&#243;n fueron prescriptas por el m&#233;dico responsable, siendo documentadas a trav&#233;s del llenado de la ficha cl&#237;nica, enfatizando: heparinas fraccionadas y de bajo peso molecular, tirofiban, AAS, clopidogrel, ticlopidina, nitrato, betabloqueante, bloqueador de canal de calcio, inhibidor de la enzima de conversi&#243;n de angiotensina, nitrato, insulina, hipoglicemiante oral<sup>15</sup>.</p>
      <p>
        <bold>2.5. An&#225;lisis estad&#237;stico</bold>
      </p>
      <p>Un total de 1.282 pacientes sometidos a 1.410 cateterismos card&#237;acos fueron evaluados para esclarecimiento diagn&#243;stico de EAC, y terap&#233;utico para tratamiento de estenosis coronarias, de acuerdo con los criterios de inclusi&#243;n y exclusi&#243;n.</p>
      <p>Las variables cuantitativas fueron presentadas como medias y desv&#237;os-est&#225;ndar y las frecuencias absolutas y relativas a las variables cualitativas fueron calculadas.</p>
      <p>Para comparar las asociaciones entre las variables cl&#237;nicas y angiogr&#225;ficas y la ocurrencia de &#243;bito, fueron utilizados los tests del qui cuadrado o test exacto de Fisher. Las edades fueron divididas en tres franjas et&#225;reas (&lt; 60 a&#241;os, 60 - 74 a&#241;os y <underline>&gt;</underline> 75 a&#241;os).</p>
      <p>Para comparar las distribuciones del clearance de creatinina entre los pacientes menores de 75 a&#241;os o con 75 a&#241;os o m&#225;s fue utilizada la ANOVA no param&#233;trica Kruskal-Wallis.</p>
      <p>Para estudiar las correlaciones cl&#237;nicas y angiogr&#225;ficas y &#243;bito, de forma multivariada, el modelo de regresi&#243;n log&#237;stica con proceso de selecci&#243;n de variables stepwise fue utilizado.</p>
      <p>El nivel de significancia usado fue de 5,0%.</p>
      <p>
        <bold>Resultados</bold>
      </p>
      <p>
        <bold>An&#225;lisis global de la poblaci&#243;n estudiada</bold>
      </p>
      <p>En el per&#237;odo estudiado, 1.410 cateterismos card&#237;acos fueron realizados en 1.282 pacientes para esclarecimiento diagn&#243;stico de EAC. La <xref ref-type="table" rid="t1-body3">Tabla 1</xref> discrimina las principales caracter&#237;sticas cl&#237;nicas basales de la poblaci&#243;n estudiada. Fueron 688 (54,0%) pacientes del sexo masculino, con media de edad de 65,4 a&#241;os (&#177; 10,9), siendo 20,1% encima de los 75 a&#241;os. Entre los factores de riesgo cl&#225;sicos para EAC, los m&#225;s frecuentes fueron la hipertensi&#243;n arterial sist&#233;mica y la dislipidemia. La diabetes mellitus estuvo presente en 31,6% de los pacientes.</p>
      <table-wrap id="t1-body3">
        <graphic xlink:href="1678-4170-abc-95-04-0422-00127-gt01-es.jpg"/></table-wrap>
      <p>EL cuadro cl&#237;nico confirmado que m&#225;s desencaden&#243; los cateterismos fue el de SCA sin SST (38,7%). Entre los IAM con SST, la ICP primaria fue realizada en apenas 19,0%; 77,0% fueron transferidos de los hospitales de origen tard&#237;amente (ICP tard&#237;a) y no recibieron trombol&#237;tico previo, 4,0% realizaron ICP de rescate (Gr&#225;fico 1). Entre los pacientes que no fueron encaminados para ICP primaria, apenas 12,0% de los pacientes recibieron trombol&#237;tico.</p>
      <p>Enfermedad arterial coronaria multiarterial ocurri&#243; en 46,4% de las coronariograf&#237;as, siendo indicada ICP en 464 pacientes y tratadas 547 lesiones-blanco (tipo B2 o C en 86,6%), localizadas en su mayor&#237;a en los vasos nativos (94,7%) y tratados con stents, siendo 14,6% con stent farmacol&#243;gico (<xref ref-type="table" rid="t2-body3">Tabla 2</xref>).</p>
      <table-wrap id="t2-body3">
        <graphic xlink:href="1678-4170-abc-95-04-0422-00127-gt02-es.jpg"/></table-wrap>
      <p>El &#233;xito del procedimiento fue obtenido en 94,2% de las ICPs. Cuando analizados por cuadro cl&#237;nico, los pacientes con SCA sin SST y los con SST sometidos a angioplastia dentro de las primeras 12 horas presentaron &#233;xito en 97,1%, mientras que los pacientes con SCA con SST tratados tard&#237;amente (&gt; 24 horas) y que manten&#237;an evidencia cl&#237;nica de isquemia, como angina post-infarto, edema agudo de pulm&#243;n atribuido a la isquemia, entre otras presentaciones consideradas por el m&#233;dico cl&#237;nico del paciente como resultado de isquemia, presentaron &#233;xito en 90,4%. Entre los pacientes con angina estable y manifestaciones at&#237;picas de EAC, el &#233;xito del procedimiento fue obtenido en 97,2% y 100,0%, respectivamente.</p>
      <p>
        <graphic xlink:href="1678-4170-abc-95-04-0422-00127-e01-es.jpg"/></p>
      <p>El IAM despu&#233;s de ICP fue observado en 2,8% de los pacientes, entre estos, un paciente con trombosis aguda (primeras 24 horas despu&#233;s de la ICP) de stent farmacol&#243;gico (Supralimus 2,5 x 39 mm), posiblemente debido a la hipoexpansi&#243;n del stent en una porci&#243;n de la lesi&#243;n con intensa calcificaci&#243;n de la arteria. No hubo necesidad de RM de urgencia (<xref ref-type="table" rid="t3-body3">Tabla 3</xref>).</p>
      <table-wrap id="t3-body3">
        <graphic xlink:href="1678-4170-abc-95-04-0422-00127-gt03-es.jpg"/></table-wrap>
      <p>Entre los pacientes sometidos a coronariograf&#237;a, la insuficiencia renal secundaria a nefropat&#237;a inducida por el contraste ocurri&#243; en 20 pacientes (1,6%), de los cuales un cuarto necesit&#243; di&#225;lisis como terap&#233;utica. El sangrado de la v&#237;a de acceso arterial ocurri&#243; en un paciente (v&#237;a femoral), habiendo necesidad de transfusi&#243;n sangu&#237;nea. No fue observado pseudoaneurisma en el local de la punci&#243;n y tampoco fue observada isquemia del miembro inferior o superior (en el caso de procedimiento v&#237;a radial), AVE isqu&#233;mico o hemorr&#225;gico.</p>
      <p>&#211;bito despu&#233;s de ICP ocurri&#243; en 5,2%, media de edad de 75,2 &#177; 10,2 a&#241;os. El n&#250;mero de vasos afectados por lesiones graves present&#243; asociaci&#243;n con la mortalidad intrahospitalaria: uno, dos, tres vasos o tronco de coronaria izquierda presentaron mortalidad de 0,54%, 3,33% y 3,41%, respectivamente (p = 0,0005).</p>
      <p>Las medicaciones m&#225;s utilizadas por los pacientes en el momento de la realizaci&#243;n del cateterismo (<xref ref-type="table" rid="t4-body3">Tabla 4</xref>) fueron AAS (65,7%) y estatina (52,3%). Globalmente, los pacientes sometidos a ICP recibieron terapia antiplaquetaria doble (AAS y clopidogrel) despu&#233;s de la realizaci&#243;n de la angioplastia (97,3%).</p>
      <table-wrap id="t4-body3">
        <graphic xlink:href="1678-4170-abc-95-04-0422-00127-gt04-es.jpg"/></table-wrap>
      <p>El tiempo de internaci&#243;n hospitalaria fue mayor en los pacientes con cuadro cl&#237;nico de SCA (13,7 d&#237;as).</p>
      <p>
        <bold>An&#225;lisis comparativo entre pacientes con edad menor que 75 a&#241;os y mayor o igual a 75 a&#241;os</bold>
      </p>
      <p>Los pacientes de 75 a&#241;os o m&#225;s presentaron clearance de creatinina (Clcr) menor que los pacientes menores de 75 a&#241;os (42,06 y 68,18 l/min/1,73m<sup>2</sup>, respectivamente; p &lt; 0,00001). En el an&#225;lisis comparativo con el g&#233;nero masculino, las pacientes del sexo femenino sometidas a cateterismo card&#237;aco eran m&#225;s a&#241;osas.</p>
      <p>La mortalidad en los mayores de 75 a&#241;os fue mayor que en los menores de 75 a&#241;os (5,0% versus 1%; p=0,000097), as&#237; como en los con IRC previa (5,3% versus 1,3%; p = 0,0028), seg&#250;n visualizado en la <xref ref-type="table" rid="t5-body3">Tabla 5</xref>. Todos los &#243;bitos fueron en pacientes con diagn&#243;stico de SCA (con supra ST = 37,5%; sin supra de ST = 62,5%).</p>
      <table-wrap id="t5-body3">
        <graphic xlink:href="1678-4170-abc-95-04-0422-00127-gt05-es.jpg"/></table-wrap>
      <p>
        <bold>Discusi&#243;n</bold>
      </p>
      <p>El presente estudio es el primer registro sobre las caracter&#237;sticas cl&#237;nicas y angiogr&#225;ficas de la poblaci&#243;n de servidores del estado de S&#227;o Paulo sometidos a cateterismos card&#237;acos para esclarecimiento diagn&#243;stico de enfermedad arterial coronaria y terap&#233;utico para tratamiento de estenosis coronarias en el Servicio de Hemodin&#225;mica y Cardiolog&#237;a Intervencionista del Hospital del Servidor P&#250;blico Estadual (HSPE) - Francisco Morato de Oliveira (FMO) del IAMSPE.</p>
      <p>La poblaci&#243;n atendida en el HSPE-FMO del IAMSPE se caracteriza por la prevalencia de a&#241;osos y los pacientes encima de 70 a&#241;os son responsables por cerca de 30,0% de las internaciones, informaci&#243;n de gran importancia puesto que tales pacientes son frecuentemente excluidos de ensayos cl&#237;nicos. Podemos tambi&#233;n evaluar la utilizaci&#243;n y la adherencia de los m&#233;dicos a modalidades terap&#233;uticas. Con este registro, describimos una poblaci&#243;n espec&#237;fica, presentando su perfil y como se ha conducido la investigaci&#243;n diagn&#243;stica de la EAC y el tratamiento de esta entidad cl&#237;nica a la luz de las directrices recomendadas y de inn&#250;meros ensayos cl&#237;nicos.</p>
      <p>Seg&#250;n datos de la Fundaci&#243;n Seade, el n&#250;mero de a&#241;osos en el Estado de S&#227;o Paulo es 4,3 millones y, de este total, 1,9 mill&#243;n est&#225; compuesto por personas con 70 a&#241;os o m&#225;s de edad (<ext-link ext-link-type="uri" xlink:href="http://www.seade.org.br">www.seade.org.br</ext-link>). En 2020, tendremos 7,1 millones de a&#241;osos en el estado de S&#227;o Paulo, de este total, 2,9 millones constituidos por personas con 70 a&#241;os o m&#225;s. De ah&#237; la gran importancia de estudios epidemiol&#243;gicos en poblaciones que presenten prevalencia de a&#241;osos.</p>
      <p>Una de las observaciones m&#225;s importantes fue el gran n&#250;mero de pacientes con SCA sin supra de ST (38,7%) atendidos en un hospital general, n&#250;mero este comparable a los 40,0% de centros de emergencia en cardiolog&#237;a<sup>16</sup>. La realizaci&#243;n de la coronariograf&#237;a permite la identificaci&#243;n precisa de la extensi&#243;n y de la gravedad de las obstrucciones coronarias, complementa la estratificaci&#243;n pron&#243;stica y la identificaci&#243;n de la m&#225;s apropiada forma de tratamiento (cl&#237;nico, revascularizaci&#243;n percut&#225;nea o quir&#250;rgica), por la anatom&#237;a coronaria mostrada angiograficamente.</p>
      <p>Dos estrategias emergen para el tratamiento de esos enfermos: estrategia invasiva precoz, realizaci&#243;n de la coronariograf&#237;a en hasta 72 horas; y estrategia conservadora, despu&#233;s de 72 horas de la admisi&#243;n hospitalaria<sup>17,18</sup>. Aunque no haya unanimidad en cuanto a la mejor estrategia, las evidencias m&#225;s recientes apoyan la estrategia invasiva precoz. El conjunto de esos ensayos es favorable a la prescripci&#243;n de la "estrategia invasiva", pues redujo la mortalidad y la ocurrencia de infarto tard&#237;o as&#237; como la rehospitalizaci&#243;n por SCA<sup>18-21</sup>.</p>
      <p>En este registro, aplicamos la estrategia invasiva precoz procurando identificar pacientes de m&#225;s alto riesgo, como portadores de EAC multiarterial grave (23,0%) y estenosis en el tronco de la coronaria izquierda (2,0%). A despecho de esa conducta, observamos una demora en la indicaci&#243;n del cateterismo, siendo el paciente encaminado a hemodin&#225;mica muchas veces apenas cuando son admitidos en la unidad coronaria o enfermer&#237;a de cardiolog&#237;a, despu&#233;s de la evaluaci&#243;n hecha por un cardi&#243;logo. Tal conducta posiblemente se reflej&#243; en un mayor per&#237;odo de internaci&#243;n hospitalaria.</p>
      <p>En los pacientes con SCA con SST, el tiempo transcurrido entre el comienzo del dolor y la recanalizaci&#243;n coronaria, qu&#237;mica o mec&#225;nica, es el factor fundamental para el beneficio del tratamiento, tanto inmediato como tard&#237;o, considerando la relaci&#243;n con la mortalidad y con la morbilidad, en pacientes tratados en hasta 12 horas del comienzo del dolor. Dato preocupante, en relaci&#243;n a los pacientes con tal diagn&#243;stico transferidos de otros hospitales, es el hecho de que los mismos no reciban la terap&#233;utica de reperfusi&#243;n adecuada, ya sea por el retardo en la transferencia o por la no administraci&#243;n de trombol&#237;tico previo (apenas 19,0% de ICP primaria en las primeras 12 horas y 12,0% de trombol&#237;tico en este registro). Tal hecho repercuti&#243; en el &#237;ndice de &#233;xito del procedimiento como descripto en los resultados, pues los pacientes sometidos a ICP dentro de las primeras 12 horas presentaron &#233;xito en 97,1% y los sometidos a ICP tard&#237;amente, 90,4% (ICP fue realizada, pues, seg&#250;n el estado cl&#237;nico de los pacientes, hab&#237;a evidencia cl&#237;nica de isquemia mioc&#225;rdica).</p>
      <p>Los estudios demostraron que la prescripci&#243;n electiva de ICP para una arteria coronaria ocluida con el plazo de uno a 28 d&#237;as, despu&#233;s de la ocurrencia de IAM en pacientes estables, no propici&#243; ning&#250;n beneficio superior a aquel ofrecido por la terap&#233;utica cl&#237;nica compuesta de &#225;cido acetilsalic&#237;lico, betabloqueantes, inhibidores de la enzima de conversi&#243;n y estatinas, en la preservaci&#243;n de la funci&#243;n contr&#225;ctil del ventr&#237;culo izquierdo y de nuevos eventos cardiovasculares<sup>22,23</sup>.</p>
      <p>Datos de la literatura comprobaron las ventajas de la ICP primaria, si es comparada a la fibrin&#243;lisis. La ICP primaria es capaz de restablecer el flujo coronario epic&#225;rdico normal (TIMI grado 3) en m&#225;s de 90,0% de los pacientes, que es asociado a reducidas tasas de isquemia recurrente y reinfarto, sin el riesgo de la ocurrencia de complicaciones hemorr&#225;gicas graves, como AVE<sup>24-26</sup>.</p>
      <p>Grupos de pacientes considerados de alto riesgo, como los a&#241;osos, frecuentemente tienen la indicaci&#243;n de coronariograf&#237;a retardada o evitada, en evidente contradicci&#243;n a la literatura<sup>27,28</sup>. Esa estrategia priva esos pacientes de la posibilidad de tratamiento, pues los mismos tendr&#237;an mayor beneficio en la revascularizaci&#243;n precoz, reflejadas en las tasas de mortalidad y/o reinfarto. Ese comportamiento parece no ocurrir en este registro, vista la media de edad de 65,4 a&#241;os (&#177; 10,9) de los pacientes sometidos a cateterismo, siendo 20,1% con 75 a&#241;os o m&#225;s.</p>
      <p>En las SCA, los a&#241;osos tienen mayor incidencia de complicaciones, lo que implica la necesidad de tratamiento m&#225;s intensivo. Mientras tanto, especialmente en aquellos encima de 75 a&#241;os, frecuentemente la terap&#233;utica m&#225;s adecuada, con betabloqueante, AAS, anticoagulante y hipolipemiante, no es utilizada<sup>9,29</sup>. Durante el per&#237;odo intrahospitalario, esa diferencia en la prescripci&#243;n medicamentosa no fue observada en este registro.</p>
      <p>Nuestro estudio constat&#243; que, entre los pacientes sometidos a ICP, los de 75 a&#241;os o m&#225;s tuvieron una mortalidad mayor, a pesar de que el &#233;xito angiogr&#225;fico fue similar a los menores de 75 a&#241;os. Las complicaciones contin&#250;an m&#225;s frecuentes en los pacientes mayores; la prevalencia de insuficiencia renal post-procedimiento decurrente de la nefropat&#237;a inducida por el contraste fue compatible con la de la literatura.</p>
      <p>Mehran et al<sup>30</sup> evaluaron los varios factores de riesgo para nefropat&#237;a inducida por contraste, determinando un escore de estratificaci&#243;n de riesgo para el desarrollo de insuficiencia renal aguda despu&#233;s de ICP. Considerando que la poblaci&#243;n a&#241;osa presenta reducida tasa de filtraci&#243;n glomerular, es de presumir que la nefropat&#237;a inducida por el contraste ocurrir&#237;a m&#225;s frecuentemente en este grupo de individuos. Aunque ese evento pueda ser previsto, la morbilidad relacionada aun es significativa, haciendo que ese riesgo sea considerado en la indicaci&#243;n del procedimiento. En casos de pacientes con alta probabilidad de nefropat&#237;a inducida por el contraste, medidas profil&#225;cticas, como hidrataci&#243;n, uso de contraste de bajo peso molecular y medidas alternativas, como hidrataci&#243;n con bicarbonato<sup>31</sup> y N-acetilcisteina<sup>32</sup>, deben ser consideradas.</p>
      <p>El aumento del riesgo de desarrollar insuficiencia renal aguda tambi&#233;n ha sido reportado en pacientes con insuficiencia renal cr&#243;nica con SCA sin SST sometidos a ICP precoz<sup>33,34</sup>. En ese grupo de pacientes, la profilaxia de insuficiencia renal aguda puede ser realizada y, normalmente, es posible obtener la estabilidad cl&#237;nica de los pacientes antes de la intervenci&#243;n, diferentemente de los pacientes con SCA con SST sometidos a ICP primaria, en los cuales no es posible la realizaci&#243;n de hidrataci&#243;n previa y la inestabilidad hemodin&#225;mica es m&#225;s frecuente.</p>
      <p>Nuestro registro identific&#243; que pacientes con insuficiencia renal cr&#243;nica tuvieron mayor mortalidad intrahospitalaria, a pesar de que realizamos preparaci&#243;n renal y evitamos la estrategia invasiva precoz en estos pacientes.</p>
      <p>Pacientes a&#241;osos son m&#225;s frecuentemente multiarteriales. El tiempo de sobrevida disminuye con el afectaci&#243;n de vasos adicionales, con el compromiso de la descendente anterior y con disfunci&#243;n ventricular izquierda<sup>35,36</sup>.</p>
      <p>Nuestro an&#225;lisis demuestra que tanto pacientes a&#241;osos como m&#225;s j&#243;venes pueden beneficiarse de la ICP, con altos &#237;ndices de &#233;xito, hecho que tambi&#233;n ha sido observado por otros autores<sup>37,38</sup>. La edad no puede ser considerada un factor limitante de los procedimientos percut&#225;neos.</p>
      <p>Conclusi&#243;n</p>
      <p>En la poblaci&#243;n estudiada, observamos predominio de a&#241;osos, siendo 20,1% encima de los 75 a&#241;os y del sexo masculino. Entre los factores de riesgo para EAC, los m&#225;s frecuentes fueron hipertensi&#243;n arterial sist&#233;mica y dislipidemia. Ocurri&#243; el predominio del s&#237;ndrome coronario agudo. La edad mayor o igual a 75 a&#241;os, EAC multiarterial e insuficiencia renal cr&#243;nica fueron los predictores de &#243;bito intrahospitalario en los pacientes sometidos a ICP.</p>
      <p>Los pacientes con edad mayor o igual a 75 a&#241;os presentaron perfil cl&#237;nico/angiogr&#225;fico de mayor riesgo y tasa de &#233;xito del procedimiento semejantes a los de pacientes m&#225;s j&#243;venes, demostrando ser la ICP una t&#233;cnica segura y eficaz en este grupo de pacientes.</p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiamiento</bold>
      </p>
      <p>El presente estudio no tuvo fuentes de financiamiento externas.</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>Este art&#237;culo es parte de disertaci&#243;n de Maestr&#237;a de Micheli Zanotti Galon por el Instituto de Asistencia M&#233;dica al Servidor P&#250;blico Estadual.</p>
      <p>
        <bold>Referencias</bold>
      </p>
    </body>
  </sub-article>
</article>
